No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d2x7yB_, 1.0000, 0.00, 1.000, 439, 439, P450 BM3 F87A IN COMPLEX WITH DMSO
2, d4h24C_, 0.9967, 0.43, 0.970, 456, 439, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
3, d4h24A_, 0.9959, 0.49, 0.970, 457, 439, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
4, d2uwhA_, 0.9954, 0.51, 0.993, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
5, d1zo9A_, 0.9954, 0.52, 0.995, 458, 439, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
6, d4h24B_, 0.9951, 0.39, 0.973, 452, 438, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
7, d1jpzA_, 0.9951, 0.54, 0.998, 456, 439, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
8, d5jq2A_, 0.9950, 0.53, 0.993, 457, 439, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
9, d5jqvF_, 0.9947, 0.55, 0.986, 455, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
10, d1zo9B_, 0.9947, 0.55, 0.998, 458, 439, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
11, d5ucwB_, 0.9946, 0.42, 0.966, 453, 438, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
12, d4zf8A_, 0.9946, 0.56, 0.989, 460, 439, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND METYRAPONE
13, d1jpzB_, 0.9946, 0.55, 0.998, 458, 439, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
14, d5jqvC_, 0.9943, 0.57, 0.989, 452, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
15, d5e9zC1, 0.9943, 0.57, 0.977, 444, 439, CYTOCHROME P450 BM3 MUTANT M11
16, d5dypC_, 0.9942, 0.59, 0.993, 450, 439, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
17, d1smjA_, 0.9942, 0.57, 0.995, 455, 439, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
18, d1fagA_, 0.9941, 0.58, 0.998, 455, 439, STRUCTURE OF CYTOCHROME P450
19, d5jqvD_, 0.9939, 0.59, 0.989, 454, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
20, d4zf6A_, 0.9939, 0.60, 0.989, 460, 439, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND PEG
21, d3cbdB_, 0.9939, 0.59, 0.973, 455, 439, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
22, d4zfaA_, 0.9938, 0.60, 0.998, 460, 439, CYTOCHROME P450 WILD TYPE FROM BM3 WITH BOUND PEG
23, d2ij4B_, 0.9938, 0.47, 0.995, 455, 438, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
24, d1fagD_, 0.9938, 0.60, 0.995, 455, 439, STRUCTURE OF CYTOCHROME P450
25, d1fagC_, 0.9937, 0.61, 0.995, 455, 439, STRUCTURE OF CYTOCHROME P450
26, d1fagB_, 0.9937, 0.60, 0.998, 455, 439, STRUCTURE OF CYTOCHROME P450
27, p4h23B_, 0.9936, 0.48, 0.968, 448, 438, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
28, d2uwhE_, 0.9936, 0.61, 0.995, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
29, d4zfbA_, 0.9935, 0.61, 0.989, 460, 439, CYTOCHROME P450 PENTAMUTANT FROM BM3 BOUND TO PALMITIC ACID
30, d1smjB_, 0.9935, 0.61, 0.995, 455, 439, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
31, d1smiB_, 0.9935, 0.49, 0.995, 455, 438, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
32, d1smjC_, 0.9934, 0.61, 0.995, 455, 439, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
33, d5jquC_, 0.9933, 0.62, 0.984, 453, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
34, d4kpaA1, 0.9933, 0.64, 0.995, 456, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 IN COMPLEX WITH N- PALMITOYLGLYCINE (NPG)
35, d1zoaA_, 0.9931, 0.52, 0.993, 457, 438, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
36, d5jqvA_, 0.9930, 0.52, 0.989, 453, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
37, d5jquF_, 0.9930, 0.63, 0.984, 455, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
38, d3cbdA_, 0.9930, 0.64, 0.973, 455, 439, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
39, d2uwhC_, 0.9929, 0.65, 0.993, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
40, p4h23A_, 0.9927, 0.54, 0.968, 454, 438, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
41, d2x7yA_, 0.9924, 0.41, 1.000, 437, 437, P450 BM3 F87A IN COMPLEX WITH DMSO
42, d1zoaB_, 0.9921, 0.57, 0.993, 457, 438, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
43, d5jq2B_, 0.9920, 0.68, 0.991, 459, 439, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
44, d2uwhB_, 0.9919, 0.68, 0.993, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
45, d5jqvE_, 0.9918, 0.58, 0.989, 451, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
46, d5jquE_, 0.9917, 0.59, 0.984, 451, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
47, d5jquD_, 0.9917, 0.70, 0.982, 454, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
48, d5xhjB_, 0.9916, 0.47, 0.998, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
49, d3kx3A_, 0.9914, 0.48, 0.995, 454, 437, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
50, d2ij4A_, 0.9914, 0.71, 0.995, 451, 439, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
51, d5dyzA_, 0.9913, 0.61, 0.993, 445, 438, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
52, d2uwhD_, 0.9912, 0.72, 0.995, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
53, d5jqvB_, 0.9911, 0.65, 0.982, 453, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
54, d1smjD_, 0.9911, 0.62, 0.995, 454, 438, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
55, d4rsnB1, 0.9910, 0.72, 0.982, 456, 439, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
56, d4rsnA1, 0.9910, 0.72, 0.982, 456, 439, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
57, d2uwhF_, 0.9910, 0.72, 0.993, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
58, d5jqvG_, 0.9908, 0.65, 0.986, 451, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
59, d5ucwA_, 0.9907, 0.53, 0.963, 453, 437, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
60, d4kewA_, 0.9906, 0.53, 0.995, 450, 437, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
61, d3kx3B_, 0.9906, 0.53, 0.993, 456, 437, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
62, d5jquA_, 0.9905, 0.78, 0.982, 452, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
63, d4keyA_, 0.9904, 0.54, 0.995, 450, 437, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
64, d5xhjA_, 0.9903, 0.55, 0.998, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
65, d3dgiA_, 0.9903, 0.63, 0.998, 449, 437, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
66, d5e9zA_, 0.9899, 0.57, 0.979, 452, 437, CYTOCHROME P450 BM3 MUTANT M11
67, d5dyzC_, 0.9895, 0.69, 0.991, 453, 438, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
68, d5b2wB_, 0.9895, 0.46, 0.995, 452, 436, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
69, d4o4pA_, 0.9895, 0.59, 0.995, 450, 437, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
70, d5jtdA_, 0.9893, 0.81, 0.991, 458, 439, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
71, d5jquG_, 0.9893, 0.71, 0.982, 451, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
72, d5b2wA_, 0.9888, 0.50, 0.995, 452, 436, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
73, d4h24D_, 0.9888, 0.51, 0.970, 455, 436, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
74, d4wg2C_, 0.9887, 0.50, 0.963, 460, 436, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
75, d5jqvH_, 0.9884, 0.85, 0.986, 450, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
76, d4dufC_, 0.9883, 0.75, 0.986, 456, 438, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
77, d3ekfB_, 0.9880, 0.41, 0.993, 452, 435, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
78, d3ekbB_, 0.9880, 0.78, 0.989, 457, 438, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
79, d1bu7A_, 0.9879, 0.86, 0.993, 455, 439, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
80, d4wg2B_, 0.9878, 0.69, 0.963, 451, 437, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
81, p5og9B_, 0.9873, 0.72, 0.986, 454, 437, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
82, d4wg2A1, 0.9870, 0.61, 0.961, 460, 436, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
83, d3nplA_, 0.9870, 0.61, 0.961, 460, 436, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
84, d5jquB_, 0.9869, 0.47, 0.989, 456, 435, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
85, d5jquH_, 0.9865, 0.72, 0.977, 453, 437, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
86, d5dypA_, 0.9865, 0.92, 0.982, 450, 438, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
87, d3nplB_, 0.9861, 0.82, 0.993, 440, 438, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
88, d2j1mB_, 0.9860, 0.52, 0.991, 456, 435, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
89, d4hghB_, 0.9858, 0.85, 0.991, 454, 438, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
90, d4hgjA_, 0.9854, 0.93, 0.993, 455, 439, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
91, d5jtdB_, 0.9853, 0.78, 0.993, 448, 437, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
92, d5e9zB_, 0.9852, 0.95, 0.989, 458, 439, CYTOCHROME P450 BM3 MUTANT M11
93, d4duaB_, 0.9851, 0.58, 0.977, 451, 435, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
94, d2j1mA_, 0.9851, 0.96, 0.984, 457, 439, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
95, d3benB_, 0.9849, 0.89, 0.991, 454, 438, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
96, d5e78B_, 0.9847, 0.95, 0.991, 457, 439, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
97, d4ducB_, 0.9843, 0.89, 0.991, 454, 438, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
98, p5og9A_, 0.9841, 0.91, 0.986, 456, 438, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
99, d4dubB_, 0.9841, 0.86, 0.986, 454, 437, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
100, d3wspB_, 0.9839, 0.91, 0.984, 456, 438, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
101, d4dueB_, 0.9837, 0.84, 0.993, 453, 437, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
102, d4dueA_, 0.9837, 0.93, 0.982, 450, 438, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
103, d4dudB_, 0.9836, 0.93, 0.984, 453, 438, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
104, d5b2uB_, 0.9835, 0.93, 0.982, 456, 438, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
105, d2hpdA_, 0.9834, 0.85, 0.991, 453, 437, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
106, d1zo4A_, 0.9833, 1.01, 0.993, 457, 439, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
107, d1fahA_, 0.9832, 1.01, 0.991, 456, 439, STRUCTURE OF CYTOCHROME P450
108, p5xa3A_, 0.9831, 1.02, 0.991, 455, 439, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
109, p5xa3D_, 0.9830, 0.87, 0.993, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
110, d5b2xB_, 0.9829, 0.88, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
111, p5xa3C_, 0.9827, 0.88, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
112, p5xa3B_, 0.9827, 0.89, 0.993, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
113, d3wspA_, 0.9827, 0.89, 0.993, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
114, d3ekbA_, 0.9824, 0.89, 0.991, 453, 437, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
115, d4hgjB_, 0.9823, 0.82, 0.993, 442, 436, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
116, d5b2xA_, 0.9821, 0.72, 0.993, 451, 435, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
117, p3qi8B_, 0.9818, 0.90, 0.991, 453, 437, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
118, d4hgiB_, 0.9817, 0.73, 0.961, 452, 435, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
119, d4hgiA_, 0.9817, 0.92, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
120, d2bmhA_, 0.9816, 1.06, 0.991, 455, 439, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
121, d3kx4A_, 0.9815, 1.10, 0.993, 455, 439, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
122, d5b2vB_, 0.9814, 0.93, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
123, d4hghA_, 0.9813, 0.93, 0.993, 453, 437, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
124, d5b2yB_, 0.9812, 1.07, 0.991, 455, 439, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
125, d5b2uA_, 0.9810, 0.86, 0.993, 452, 436, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
126, d4o4pB_, 0.9810, 0.94, 0.989, 453, 437, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
127, d5e9zD_, 0.9806, 0.55, 0.995, 446, 433, CYTOCHROME P450 BM3 MUTANT M11
128, d4dtzB_, 0.9806, 1.01, 0.977, 444, 437, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
129, d3benA_, 0.9805, 0.95, 0.984, 453, 437, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
130, d1smiA_, 0.9803, 0.88, 0.991, 454, 436, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
131, d5b2vA_, 0.9801, 0.70, 0.995, 439, 434, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
132, d4dtyB_, 0.9800, 0.98, 0.993, 453, 437, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
133, d5b2yA_, 0.9795, 0.97, 0.984, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
134, d4kf2B_, 0.9793, 0.92, 0.993, 452, 436, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
135, d4dtwB_, 0.9793, 1.12, 0.984, 448, 437, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
136, d3ekfA_, 0.9790, 0.99, 0.984, 453, 437, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
137, d1p0vA_, 0.9787, 0.76, 0.995, 441, 434, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
138, d5e78A_, 0.9786, 1.02, 0.989, 441, 437, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
139, d1yqoA_, 0.9786, 1.02, 0.991, 447, 437, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
140, d4du2B_, 0.9780, 1.02, 0.989, 441, 437, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
141, d2x80A_, 0.9780, 1.04, 0.977, 444, 437, P450 BM3 F87A IN COMPLEX WITH DMSO
142, d4kf0A_, 0.9779, 1.17, 0.995, 455, 439, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
143, d3ekdB_, 0.9778, 1.20, 0.984, 451, 437, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
144, d2ij3A_, 0.9777, 1.08, 0.993, 455, 438, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
145, d4hggB_, 0.9775, 1.04, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
146, d1yqpA_, 0.9775, 1.07, 0.995, 441, 436, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
147, d1p0xA_, 0.9773, 1.05, 0.991, 441, 437, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
148, d3kx5A_, 0.9772, 1.06, 0.991, 441, 437, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
149, d2nnbA_, 0.9772, 0.92, 0.991, 455, 435, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
150, d4dtzA_, 0.9770, 1.06, 0.989, 441, 437, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
151, d4du2A_, 0.9769, 1.07, 0.984, 453, 437, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
152, d1p0wA_, 0.9768, 1.07, 0.977, 443, 437, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
153, d4kewB_, 0.9767, 1.07, 0.991, 441, 437, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
154, d1jmeA_, 0.9763, 0.62, 0.995, 443, 431, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
155, d4hgfB_, 0.9760, 1.09, 0.989, 441, 437, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
156, d4dufD_, 0.9760, 1.03, 0.991, 441, 435, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
157, d4dtwA_, 0.9759, 1.17, 0.986, 456, 438, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
158, d3ekdA_, 0.9758, 1.10, 0.982, 453, 437, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
159, d4hgfA_, 0.9749, 1.20, 0.995, 454, 439, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
160, d3m4vA_, 0.9749, 1.16, 0.993, 442, 436, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
161, d4keyB_, 0.9747, 0.99, 0.991, 451, 435, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
162, d2ij2B_, 0.9739, 0.61, 0.995, 442, 430, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
163, d5e7yA_, 0.9737, 0.88, 0.993, 448, 433, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
164, d4dtyA_, 0.9733, 1.03, 0.991, 451, 435, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
165, d1bu7B_, 0.9728, 1.17, 0.984, 453, 437, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
166, d2ij3B_, 0.9725, 1.31, 0.993, 455, 439, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
167, d4kf2A_, 0.9723, 1.26, 0.991, 454, 438, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
168, d4duaA_, 0.9722, 1.34, 0.984, 451, 437, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
169, d4kpbA_, 0.9717, 1.33, 0.982, 457, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
170, d2j4sA_, 0.9717, 1.13, 0.995, 440, 435, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
171, d4kf0B_, 0.9712, 1.15, 0.991, 452, 436, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
172, d1fahB_, 0.9712, 1.24, 0.995, 441, 435, STRUCTURE OF CYTOCHROME P450
173, d3m4vB_, 0.9710, 1.36, 0.991, 455, 439, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
174, d1zo4B_, 0.9707, 1.04, 0.991, 438, 434, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
175, d4dufA_, 0.9703, 1.37, 0.991, 457, 439, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
176, d2bmhB_, 0.9703, 1.32, 0.986, 456, 438, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
177, d2hpdB_, 0.9702, 1.38, 0.993, 455, 439, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
178, d2x80B_, 0.9692, 1.39, 0.993, 457, 439, P450 BM3 F87A IN COMPLEX WITH DMSO
179, d4dubA_, 0.9688, 1.41, 0.993, 455, 439, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
180, d1yqoB_, 0.9687, 1.36, 0.984, 456, 438, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
181, d4ducA_, 0.9683, 1.31, 0.991, 441, 437, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
182, d4hggA_, 0.9678, 1.38, 0.986, 456, 438, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
183, d4dudA_, 0.9678, 0.99, 0.988, 435, 431, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
184, d2nnbB_, 0.9656, 1.39, 0.984, 456, 438, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
185, d1yqpB_, 0.9654, 1.38, 0.991, 441, 437, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
186, d1p0wB_, 0.9651, 1.39, 0.991, 441, 437, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
187, d2j4sB_, 0.9649, 1.40, 0.991, 448, 437, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
188, d5e7yB_, 0.9646, 1.23, 0.991, 450, 434, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
189, d4kpbB_, 0.9645, 1.35, 0.991, 452, 436, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
190, d3kx5B_, 0.9642, 1.36, 0.995, 444, 436, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
191, d3dgiB_, 0.9642, 1.42, 0.995, 455, 437, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
192, d1jmeB_, 0.9641, 0.56, 0.998, 425, 425, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
193, d3kx4B_, 0.9640, 1.43, 0.989, 441, 437, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
194, d1p0vB_, 0.9640, 1.49, 0.963, 454, 438, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
195, d4dufB_, 0.9639, 1.43, 0.991, 444, 437, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
196, d1p0xB_, 0.9635, 1.49, 0.957, 456, 438, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
197, d2ij2A_, 0.9621, 1.44, 0.991, 448, 437, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
198, d3hf2A_, 0.9613, 1.47, 0.991, 450, 437, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
199, d3hf2B_, 0.9466, 0.94, 0.993, 428, 427, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
200, d3psxB_, 0.9313, 1.17, 0.988, 423, 423, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
201, d3psxA_, 0.9298, 0.55, 0.988, 414, 411, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
202, d1bvyA_, 0.9298, 0.51, 0.988, 412, 410, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
203, d1bvyB_, 0.9291, 1.33, 0.990, 439, 420, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
204, p6c93A_, 0.8959, 1.29, 0.988, 438, 419, EFFECTS OF THE E310A MUTATION OF CYTOCHROME P450 4B1 (CYP4B1) ON N- OCTANE BINDING AND HEME RUFFLING 
205, p6c94A_, 0.8953, 2.54, 0.234, 478, 427, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH THE INHIBITOR HET0016 
206, p5t6qA_, 0.8933, 2.55, 0.230, 471, 427, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH OCTANE: AN N- ALKANE AND FATTY ACID OMEGA-HYDROXYLASE WITH A COVALENTLY BOUND HEME
207, d5veuC_, 0.8844, 2.36, 0.232, 461, 423, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
208, d2v0mC1, 0.8784, 2.36, 0.232, 461, 423, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
209, d2j0cC_, 0.8784, 2.64, 0.265, 469, 426,  
210, d5veuI_, 0.8775, 2.72, 0.270, 465, 426, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
211, d3na1A_, 0.8764, 2.72, 0.270, 465, 426, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
212, d2ve3A_, 0.8761, 2.61, 0.270, 464, 422, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
213, d3na0A_, 0.8749, 2.77, 0.195, 472, 426, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
214, d3na1B_, 0.8746, 2.77, 0.195, 472, 426, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
215, d3n9yA_, 0.8737, 2.47, 0.212, 435, 419, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
216, d3na0B_, 0.8736, 2.47, 0.212, 435, 419, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
217, d3n9zA_, 0.8736, 2.76, 0.195, 470, 425, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
218, d1tqnA_, 0.8735, 2.79, 0.195, 471, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 3A4
219, p5eshA_, 0.8727, 2.78, 0.193, 471, 425, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT IN COMPLEX WITH ITRACONAZOLE
220, d3n9zB_, 0.8727, 2.78, 0.195, 470, 425, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
221, p5eafA_, 0.8725, 2.78, 0.193, 470, 425, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
222, d3n9yB_, 0.8725, 2.93, 0.257, 468, 428, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
223, p5esmA_, 0.8724, 3.06, 0.137, 497, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH FLUCONAZOLE
224, d5a1pA_, 0.8724, 2.81, 0.195, 470, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE AND CITRATE
225, p5esjA_, 0.8723, 3.06, 0.137, 498, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH FLUCONAZOLE
226, p5eagA_, 0.8723, 2.80, 0.195, 470, 425, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR PROCHLORAZ
227, p5eacA_, 0.8722, 3.00, 0.135, 497, 431, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-TEBUCONAZOLE
228, p4lxjA_, 0.8722, 2.91, 0.260, 465, 427, SACCHAROMYCES CEREVISIAE LANOSTEROL 14-ALPHA DEMETHYLASE WITH LANOSTEROL BOUND
229, d5veuK_, 0.8721, 3.01, 0.132, 498, 431, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
230, d3k9yA_, 0.8721, 3.00, 0.135, 497, 431, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
231, p5eseA_, 0.8720, 3.05, 0.137, 498, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73R MUTANT COMPLEXED WITH FLUCONAZOLE
232, p5eadA_, 0.8720, 3.05, 0.137, 498, 432, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-DESTHIO-PROTHIOCONAZOLE
233, p4ze3A_, 0.8720, 2.55, 0.267, 458, 419, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH FLUCONAZOLE
234, p4ze0A_, 0.8720, 2.74, 0.198, 461, 425, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH VORICONAZOLE
235, p5esnA_, 0.8719, 3.06, 0.137, 497, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT STRUCTURE
236, p5esfA_, 0.8719, 3.01, 0.135, 497, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH FLUCONAZOLE
237, p5eafB_, 0.8719, 3.02, 0.135, 496, 431, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
238, p4wmzA_, 0.8719, 3.01, 0.135, 498, 431, S. CEREVISIAE CYP51 COMPLEXED WITH FLUCONAZOLE IN THE ACTIVE SITE
239, d2v0mA1, 0.8719, 3.01, 0.135, 497, 431, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
240, p5ul0A_, 0.8718, 3.10, 0.141, 493, 432, S. CEREVISIAE CYP51 COMPLEXED WITH VT-1161
241, d3k9vB_, 0.8718, 3.01, 0.135, 497, 431, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
242, d2j0cA_, 0.8718, 3.02, 0.135, 496, 431,  
243, d5veuJ_, 0.8717, 2.72, 0.270, 455, 423, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
244, p4zdzA_, 0.8717, 3.02, 0.135, 497, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH FLUCONAZOLE
245, p5hs1A_, 0.8716, 2.69, 0.203, 464, 424, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) COMPLEXED WITH VORICONAZOLE
246, d5veuB_, 0.8714, 2.72, 0.270, 455, 423, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
247, p5eaeA_, 0.8714, 2.65, 0.267, 458, 420, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-DESTHIO-PROTHIOCONAZOLE
248, p4ze2A_, 0.8714, 3.02, 0.135, 497, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH ITRACONAZOLE
249, p5esgA_, 0.8713, 3.06, 0.137, 497, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH ITRACONAZOLE
250, p5eslA_, 0.8711, 2.66, 0.262, 458, 420, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH ITRACONAZOLE
251, p5esiA_, 0.8710, 3.07, 0.137, 498, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT
252, p4ze1A_, 0.8710, 3.03, 0.135, 497, 431, SACCHAROMYCES CEREVISIAE CYP51 Y140F MUTANT COMPLEXED WITH POSACONAZOLE IN THE ACTIVE SITE
253, d3k9yB_, 0.8710, 3.08, 0.137, 496, 432, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
254, d6bdiA_, 0.8709, 3.04, 0.135, 497, 431, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
255, p5eqbA_, 0.8709, 3.02, 0.135, 498, 431, CRYSTAL STRUCTURE OF LANOSTEROL 14-ALPHA DEMETHYLASE WITH INTACT TRANSMEMBRANE DOMAIN BOUND TO ITRACONAZOLE
256, p5eskA_, 0.8708, 3.03, 0.135, 497, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH ITRACONAZOLE
257, d5veuD_, 0.8707, 2.71, 0.203, 462, 424, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
258, p5eahA_, 0.8707, 2.89, 0.261, 462, 426, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR DIFENOCONAZOLE
259, p5eabA_, 0.8707, 3.07, 0.137, 499, 432, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-TEBUCONAZOLE
260, p4zdyA_, 0.8707, 3.07, 0.137, 499, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH ITRACONAZOLE
261, d2v0mD1, 0.8706, 3.04, 0.132, 497, 431, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
262, d2j0cD_, 0.8706, 2.63, 0.264, 459, 420,  
263, d4i4hA_, 0.8702, 3.07, 0.137, 497, 432, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO PYRIDINE-SUBSTITUTED DESOXYRITONAVIR
264, d5veuF_, 0.8701, 3.07, 0.137, 495, 432, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
265, d6bdkA_, 0.8700, 3.09, 0.137, 497, 432, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
266, d5veuG_, 0.8698, 2.69, 0.271, 453, 421, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
267, d6bd7A_, 0.8697, 2.69, 0.271, 453, 421, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
268, d5veuH_, 0.8696, 2.72, 0.265, 457, 422, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
269, d6bczA_, 0.8695, 2.67, 0.264, 456, 420, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
270, d3mzsD_, 0.8695, 2.90, 0.261, 461, 426, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
271, d5veuA_, 0.8694, 2.69, 0.267, 455, 420, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
272, d3mzsC_, 0.8694, 2.94, 0.260, 462, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
273, d3mzsB_, 0.8693, 2.66, 0.264, 459, 420, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
274, p5tz1A_, 0.8692, 2.91, 0.261, 461, 426, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
275, d5vcgA_, 0.8691, 2.85, 0.181, 470, 425, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO BROMOERGOCRYPTINE
276, p5tz1B_, 0.8691, 2.78, 0.262, 462, 423, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
277, d5a1rA_, 0.8691, 2.85, 0.184, 470, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE
278, d4i3qA_, 0.8689, 2.85, 0.181, 470, 425, CRYSTAL STRUCTURE OF HUMAN CYP3A4 COORDINATED TO A WATER MOLECULE
279, d3mzsA_, 0.8687, 2.98, 0.147, 484, 430, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
280, d3nxuA_, 0.8684, 2.87, 0.264, 461, 424, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
281, d4k9wC_, 0.8683, 2.97, 0.144, 484, 430, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
282, d3ua1A_, 0.8680, 2.93, 0.261, 462, 426, CRYSTAL STRUCTURE OF THE CYTOCHROME P4503A4-BROMOERGOCRYPTINE COMPLEX
283, d5vcdA_, 0.8678, 2.95, 0.258, 465, 426, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO GLYCEROL
284, d3nxuB_, 0.8677, 2.88, 0.181, 470, 425, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
285, d3k9vA_, 0.8677, 2.74, 0.265, 457, 422, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
286, d4d75A_, 0.8673, 2.76, 0.270, 458, 422, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
287, d5vccA_, 0.8672, 2.83, 0.262, 456, 423, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO GLYCEROL
288, d4k9wD_, 0.8669, 2.87, 0.267, 460, 423, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
289, d5te8B_, 0.8663, 2.75, 0.268, 457, 422, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
290, d4fdhK_, 0.8661, 2.77, 0.203, 464, 424, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
291, d4k9wB_, 0.8660, 2.77, 0.203, 464, 424, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
292, d5vceA_, 0.8657, 2.92, 0.261, 460, 425, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO RITONAVIR
293, d6bd5A_, 0.8655, 2.87, 0.265, 457, 423, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
294, d5te8A_, 0.8655, 2.77, 0.268, 458, 422, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
295, p4zgxD_, 0.8654, 2.87, 0.262, 471, 423, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
296, d2ve3B_, 0.8653, 2.87, 0.262, 471, 423, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
297, d2v0mB1, 0.8653, 2.79, 0.186, 469, 424, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
298, d2j0cB_, 0.8653, 2.79, 0.186, 469, 424,  
299, d4d7dA_, 0.8652, 2.80, 0.265, 457, 422, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
300, d4d78A_, 0.8652, 2.89, 0.267, 457, 423, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
301, d4fdhD_, 0.8651, 2.92, 0.259, 457, 424, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
302, d4k9wA_, 0.8650, 2.96, 0.262, 470, 424, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
303, d4fdhE1, 0.8650, 2.74, 0.195, 465, 421, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
304, d4fdhF1, 0.8649, 2.39, 0.214, 427, 412, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
305, d4ny4A_, 0.8648, 2.75, 0.268, 451, 421, CRYSTAL STRUCTURE OF CYP3A4 IN COMPLEX WITH AN INHIBITOR
306, d6bdmA_, 0.8646, 2.75, 0.268, 451, 421, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
307, d6bd8A_, 0.8646, 2.80, 0.268, 458, 422, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
308, d4i4gA_, 0.8646, 2.76, 0.268, 459, 421, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO OXAZOLE-SUBSTITUTED DESOXYRITONAVIR
309, d4dvqF1, 0.8645, 2.68, 0.195, 465, 420, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
310, p4zgxA_, 0.8642, 2.85, 0.265, 458, 423, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
311, d1w0fA_, 0.8642, 2.63, 0.191, 464, 419, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
312, d4dvqE1, 0.8638, 2.61, 0.194, 463, 418, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
313, p4zgxJ_, 0.8637, 2.91, 0.259, 460, 424, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
314, d4d6zA_, 0.8637, 2.95, 0.264, 456, 424, CYTOCHROME P450 3A4 BOUND TO IMIDAZOLE AND AN INHIBITOR
315, p5fsaA_, 0.8635, 2.92, 0.259, 457, 424, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
316, d4fdhB_, 0.8635, 2.75, 0.264, 459, 421, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
317, d4k9tA_, 0.8634, 2.61, 0.194, 463, 418, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
318, d6bd6A_, 0.8624, 2.75, 0.190, 465, 421, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
319, d5vc0A_, 0.8623, 2.92, 0.264, 459, 424, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO RITONAVIR
320, d4fdhG_, 0.8623, 2.65, 0.189, 464, 419, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
321, p4zgxC_, 0.8620, 2.61, 0.196, 463, 418, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
322, p4zgxB_, 0.8619, 2.81, 0.264, 460, 421, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
323, p5jlcA_, 0.8617, 3.11, 0.139, 484, 431, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA GLABRATA
324, p4zgxK_, 0.8617, 2.75, 0.190, 465, 421, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
325, p4zgxH_, 0.8617, 2.87, 0.258, 455, 422, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
326, d4dvqG_, 0.8616, 2.93, 0.262, 457, 423, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
327, d3i3kA_, 0.8616, 2.93, 0.264, 463, 424,  
328, d4k9vA_, 0.8615, 2.67, 0.193, 463, 419, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
329, d3ld6A_, 0.8615, 2.72, 0.188, 465, 420, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
330, d2ve4B_, 0.8610, 2.72, 0.188, 465, 420, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
331, d5te8C_, 0.8608, 3.10, 0.124, 487, 428, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
332, d3i3kB_, 0.8607, 2.84, 0.193, 461, 420,  
333, d4uymA1, 0.8606, 2.72, 0.193, 465, 420, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
334, d4fdhA_, 0.8604, 2.62, 0.192, 462, 417, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
335, d3ld6B_, 0.8604, 2.96, 0.198, 445, 425, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
336, d2j0dA1, 0.8604, 2.85, 0.264, 456, 421, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
337, p4zgxF_, 0.8603, 2.96, 0.198, 445, 425, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
338, d4dvqB_, 0.8603, 2.64, 0.212, 432, 416, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
339, d3jusB_, 0.8603, 2.94, 0.263, 469, 422, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
340, p5fsaB_, 0.8602, 2.93, 0.203, 444, 424, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
341, d4dvqA_, 0.8602, 3.05, 0.164, 469, 426, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
342, d3jusA_, 0.8600, 2.68, 0.189, 463, 418, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
343, d4fdhC_, 0.8597, 2.93, 0.203, 444, 424, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
344, d4dvqC_, 0.8597, 2.92, 0.262, 445, 420, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
345, d3tjsA_, 0.8596, 2.70, 0.189, 464, 419, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN CYTOCHROME P450 3A4 AND DESTHIAZOLYLMETHYLOXYCARBONYL RITONAVIR
346, d4dvqD_, 0.8593, 2.68, 0.189, 463, 418, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
347, p4zgxL_, 0.8592, 2.96, 0.200, 445, 425, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
348, p3tbgA_, 0.8590, 3.13, 0.142, 483, 430, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
349, p3tbgC_, 0.8589, 2.68, 0.194, 463, 418, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
350, d2ve4A_, 0.8588, 3.00, 0.197, 445, 426, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
351, d4uhlF1, 0.8587, 2.66, 0.197, 462, 417, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
352, d5frbA1, 0.8586, 2.66, 0.192, 462, 417, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH A TETRAZOLE-BASED INHIBITOR VT-1598
353, p6cr2B_, 0.8585, 2.87, 0.271, 449, 421, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
354, p5v5zA_, 0.8585, 2.68, 0.187, 462, 417, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA ALBICANS
355, d6aycA1, 0.8583, 2.70, 0.191, 462, 418, NAEGLERIA FOWLERI CYP51-ITRACONAZOLE COMPLEX
356, p2q9fA_, 0.8583, 3.13, 0.171, 467, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1 IN COMPLEX WITH CHOLESTEROL-3-SULPHATE
357, d4dvqH_, 0.8581, 3.13, 0.171, 467, 426, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
358, p4j14A_, 0.8580, 3.20, 0.173, 467, 427, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH POSACONAZOLE BOUND
359, d5g5jA_, 0.8579, 2.70, 0.204, 431, 417, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO METFORMIN
360, d4uymB1, 0.8579, 2.78, 0.196, 442, 419, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
361, d4k9uA_, 0.8579, 3.09, 0.164, 469, 426, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
362, p6cr2A_, 0.8578, 3.08, 0.167, 469, 426, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
363, d5veuL_, 0.8578, 3.07, 0.141, 488, 426, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
364, p4zgxE_, 0.8577, 3.00, 0.191, 447, 424, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
365, d4uhlG1, 0.8576, 2.40, 0.222, 433, 405, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
366, d4uhlE1, 0.8576, 2.70, 0.189, 462, 417, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
367, d4fdhH_, 0.8576, 2.50, 0.221, 436, 407, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
368, d4uhlH1, 0.8574, 2.50, 0.221, 436, 407, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
369, d4fdhI_, 0.8574, 2.92, 0.266, 452, 421, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
370, p3mdmA_, 0.8572, 3.12, 0.167, 469, 426, THIOPERAMIDE COMPLEX OF CYTOCHROME P450 46A1
371, d4uhiD_, 0.8571, 2.91, 0.269, 450, 420, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
372, d4dvqJ_, 0.8571, 3.11, 0.164, 469, 426, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
373, d4uhlD1, 0.8570, 2.62, 0.268, 448, 414, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
374, p4kq8A_, 0.8570, 2.58, 0.193, 459, 414, STRUCTURE OF RECOMBINANT HUMAN CYTOCHROME P450 AROMATASE
375, d4uylB1, 0.8567, 2.81, 0.196, 442, 419, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
376, d4uhiA_, 0.8566, 2.80, 0.196, 442, 419, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
377, p3s79A_, 0.8566, 2.69, 0.189, 462, 417, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) REFINED AT 2.75 ANGSTROM
378, d6ay4A1, 0.8565, 2.82, 0.193, 442, 419, NAEGLERIA FOWLERI CYP51-FLUCONAZOLE COMPLEX
379, p5jl9A_, 0.8565, 2.69, 0.189, 462, 417, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #4
380, p3eqmA_, 0.8565, 2.49, 0.221, 435, 407, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE CYTOCHROME P450 IN COMPLEX WITH ANDROSTENEDIONE
381, p5jkwA_, 0.8564, 2.82, 0.196, 442, 419, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONE
382, d4uylA1, 0.8564, 2.73, 0.191, 462, 418, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
383, p5jl7A_, 0.8563, 2.82, 0.196, 442, 419, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #3
384, p5jkvA_, 0.8563, 2.92, 0.197, 452, 422, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLYCOL
385, p4zgxI_, 0.8562, 3.08, 0.167, 469, 426, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
386, d4dvqI_, 0.8562, 2.83, 0.193, 442, 419, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
387, p3s7sA_, 0.8562, 2.92, 0.197, 452, 422, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH BREAST CANCER DRUG EXEMESTANE
388, p5jl6A_, 0.8561, 3.06, 0.191, 448, 425, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2
389, d4uhlA1, 0.8561, 3.06, 0.191, 448, 425, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
390, d4k9xA_, 0.8561, 2.92, 0.197, 452, 422, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
391, d4uhlC1, 0.8559, 2.92, 0.197, 452, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
392, p3mdrA_, 0.8559, 2.92, 0.197, 452, 422, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
393, p5tftA_, 0.8558, 2.93, 0.197, 452, 422, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
394, p6b82B_, 0.8556, 3.19, 0.166, 469, 429, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
395, d4fdhL_, 0.8556, 2.93, 0.197, 452, 422, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
396, d4uhiB_, 0.8555, 2.93, 0.197, 452, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
397, d4uhiC_, 0.8554, 2.56, 0.194, 458, 413, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
398, d5tl8A1, 0.8551, 2.74, 0.196, 462, 418, NAEGLERIA FOWLERI CYP51-POSACONAZOLE COMPLEX
399, d4uhlB1, 0.8551, 2.93, 0.197, 452, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
400, d4fdhJ_, 0.8550, 2.94, 0.197, 452, 422, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
401, p4gl5A_, 0.8549, 2.84, 0.193, 442, 419, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG029 (COMPOUND 4)
402, p4fiaA_, 0.8549, 2.82, 0.264, 449, 417, CRYSTAL STRUCTURE OF HUMAN CYP46A1 P450 WITH BICALUTAMIDE BOUND
403, p3qm4A_, 0.8549, 2.84, 0.196, 442, 419, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
404, p4wnvA_, 0.8543, 2.51, 0.222, 427, 406, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
405, p3mdrB_, 0.8542, 3.18, 0.171, 467, 426, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
406, p4gl7A_, 0.8540, 3.22, 0.194, 470, 428, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG046 (COMPOUND 5)
407, d3k1oA_, 0.8539, 3.22, 0.194, 470, 428, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH A POTENTIAL ANTICHAGASIC DRUG POSACONAZOLE
408, d6aybA1, 0.8538, 2.57, 0.194, 456, 413, NAEGLERIA FOWLERI CYP51-KETOCONAZOLE COMPLEX
409, d1w0gA_, 0.8536, 2.84, 0.196, 442, 419, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
410, d2wuzB_, 0.8535, 2.86, 0.193, 442, 419, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
411, d2j0dB1, 0.8535, 3.03, 0.194, 446, 423, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
412, d6ay6A1, 0.8534, 2.87, 0.191, 442, 419, NAEGLERIA FOWLERI CYP51-VORICONAZOLE COMPLEX
413, p3mdtB_, 0.8532, 2.77, 0.187, 462, 418, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
414, p3tdaC_, 0.8528, 2.95, 0.197, 452, 422, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
415, p3qm4B_, 0.8527, 2.46, 0.222, 426, 405, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
416, p4enhA_, 0.8525, 3.11, 0.177, 465, 424, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH FLUVOXAMINE BOUND
417, p3mdvB_, 0.8525, 3.10, 0.173, 464, 423, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
418, p3mdvA_, 0.8525, 2.43, 0.223, 425, 404, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
419, d4g7gC_, 0.8523, 2.97, 0.197, 452, 422, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
420, d3zg2A_, 0.8523, 2.81, 0.187, 442, 418, STEROL 14 ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR (S)-2-(4-CHLOROPHENYL)-2- (PYRIDIN-3-YL)-1-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL) ETHANONE (EPL-BS1246UDO)
421, d4dvqK_, 0.8522, 3.01, 0.192, 445, 422, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
422, p2q9gA_, 0.8520, 2.99, 0.267, 455, 420, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1
423, p3tdaA_, 0.8519, 2.94, 0.183, 444, 421, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
424, d4dvqL_, 0.8518, 2.86, 0.262, 441, 416, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
425, p6b82A_, 0.8513, 3.05, 0.191, 446, 423, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
426, d4cohB_, 0.8512, 2.37, 0.221, 424, 403, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
427, d3l4dB1, 0.8512, 3.24, 0.171, 467, 426, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
428, p3mdtA_, 0.8511, 3.31, 0.172, 457, 425, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
429, d3l4dC1, 0.8511, 2.46, 0.223, 426, 404, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
430, d3l4dA1, 0.8509, 2.39, 0.221, 424, 403, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
431, d3l4dD1, 0.8508, 2.39, 0.221, 424, 403, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
432, d3zg3A_, 0.8504, 2.74, 0.184, 448, 414, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR N-(1-(5-( TRIFLUOROMETHYL)(PYRIDIN-2-YL))PIPERIDIN-4YL)-N-(4-( TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-AMINE (EPL-BS967 UDD)
433, d4g7gB_, 0.8502, 2.93, 0.186, 449, 420, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
434, d3juvA_, 0.8502, 2.74, 0.190, 460, 416, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51)
435, p4xryA_, 0.8499, 2.50, 0.220, 422, 404, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
436, d4cohA_, 0.8498, 3.25, 0.171, 467, 426, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
437, d3gw9A_, 0.8498, 2.57, 0.192, 454, 411, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
438, d3gw9D_, 0.8497, 3.05, 0.199, 465, 422, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
439, d3g1qB_, 0.8497, 3.00, 0.185, 445, 421, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
440, p4wnwA_, 0.8495, 2.87, 0.189, 445, 418, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
441, d4g3jC_, 0.8495, 2.41, 0.223, 424, 403, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
442, d3p99D_, 0.8495, 2.81, 0.187, 444, 417, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
443, d2x2nA_, 0.8494, 2.82, 0.187, 445, 417, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
444, d2x2nC_, 0.8492, 2.88, 0.189, 441, 418, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
445, d2wuzA_, 0.8492, 2.86, 0.187, 445, 418, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
446, d4h6oA1, 0.8491, 2.75, 0.184, 448, 414, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE INHIBITOR NEU321 (1-(3-(4-CHLORO-35-DIMETHYLPHENOXY) BENZYL)-1H-IMIDAZOLE
447, d4ck8B1, 0.8491, 3.14, 0.190, 448, 422, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
448, d4ck8A1, 0.8491, 3.14, 0.190, 448, 422, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
449, d3p99A_, 0.8490, 3.19, 0.173, 464, 423, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
450, d4g7gD_, 0.8487, 2.89, 0.182, 442, 418, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
451, d5veuE_, 0.8486, 2.85, 0.185, 450, 416, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
452, d3g1qD_, 0.8486, 2.85, 0.185, 450, 416, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
453, d3g1qC_, 0.8486, 2.83, 0.186, 449, 415, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
454, d2x2nD_, 0.8485, 2.90, 0.184, 444, 418, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
455, d3p99C_, 0.8484, 3.14, 0.175, 461, 422, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
456, d3gw9C_, 0.8484, 2.80, 0.184, 448, 414, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
457, d4g3jA_, 0.8483, 2.92, 0.184, 448, 418, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
458, d3khmA_, 0.8481, 2.81, 0.186, 448, 415, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH INHIBITOR FLUCONAZOLE
459, d4g3jD_, 0.8479, 2.77, 0.188, 441, 414, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
460, d4bmmB1, 0.8479, 2.91, 0.182, 444, 418, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
461, d1w0eA_, 0.8479, 2.88, 0.187, 434, 418, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
462, d2x2nB_, 0.8477, 2.87, 0.187, 446, 417, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
463, d5ajrA1, 0.8475, 2.89, 0.187, 446, 417, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE 1-TETRAZOLE DERIVATIVE VT-1161 ((R)-2-( 24-DIFLUOROPHENYL)-11-DIFLUORO-3-(1H-TETRAZOL-1-YL)-1-(5- (4-(222-TRIFLUOROETHOXY)PHENYL)PYRIDIN-2-YL)PROPAN-2-OL)
464, d4bjkD1, 0.8473, 2.92, 0.187, 448, 418, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
465, d3g1qA_, 0.8471, 2.79, 0.184, 448, 414, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
466, d1nr6A1, 0.8469, 2.58, 0.274, 441, 409, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH DICLOFENAC
467, d4ck9A1, 0.8468, 2.90, 0.185, 448, 417, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-CHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFT)
468, d2wv2A_, 0.8468, 2.79, 0.188, 447, 414, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA BRUCEI IN COMPLEX WITH FLUCONAZOLE
469, d6bdhA_, 0.8467, 2.78, 0.188, 447, 414, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
470, d4ckaA1, 0.8467, 2.94, 0.184, 444, 418, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-FLUOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFS)
471, d4c27B_, 0.8467, 2.91, 0.187, 449, 418, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
472, d3dl9B2, 0.8464, 2.92, 0.184, 448, 418, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
473, d4c27A_, 0.8463, 3.00, 0.189, 441, 419, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
474, d3p99B_, 0.8463, 2.82, 0.178, 448, 415, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
475, d4g7gA_, 0.8462, 2.85, 0.190, 440, 416, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
476, d3c6gB2, 0.8462, 2.91, 0.264, 450, 416, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
477, d2ojdB1, 0.8462, 2.79, 0.186, 444, 414,  
478, d4bjkC1, 0.8458, 2.92, 0.189, 446, 417, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
479, d3gw9B_, 0.8454, 2.77, 0.189, 441, 413, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
480, d4g3jB_, 0.8453, 2.95, 0.179, 448, 418, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
481, d4c28B_, 0.8453, 3.30, 0.181, 461, 426, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
482, d4bjkA1, 0.8453, 2.80, 0.188, 431, 415, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
483, d4bjkB1, 0.8451, 2.81, 0.188, 443, 414, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
484, d3czhB1, 0.8451, 2.82, 0.266, 439, 413, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
485, p4xrzB_, 0.8447, 2.81, 0.188, 431, 415, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
486, d4c28A_, 0.8446, 2.98, 0.189, 443, 419, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
487, d3tikC1, 0.8446, 3.19, 0.212, 463, 424, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
488, d3tikB1, 0.8446, 3.02, 0.188, 444, 420, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
489, d4bmmA1, 0.8442, 2.91, 0.187, 448, 417, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
490, p4wnwB_, 0.8440, 2.87, 0.178, 448, 415, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
491, d3tikA1, 0.8440, 3.19, 0.212, 463, 424, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
492, d3dl9A2, 0.8439, 3.20, 0.217, 463, 424, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
493, d2vn0A_, 0.8437, 2.80, 0.186, 447, 413, CYP2C8DH COMPLEXED WITH TROGLITAZONE
494, d1n6bA1, 0.8430, 3.01, 0.181, 449, 419, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH A DIMETHYL DERIVATIVE OF SULFAPHENAZOLE
495, d2ojdA1, 0.8429, 2.90, 0.178, 448, 415,  
496, d4i8vB1, 0.8426, 2.97, 0.189, 441, 418, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
497, d3c6gA1, 0.8422, 2.81, 0.186, 447, 413, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
498, d4c0cA1, 0.8420, 2.82, 0.186, 447, 413, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(24-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
499, d3czhA1, 0.8419, 3.19, 0.213, 462, 423, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
500, d4bmmD1, 0.8418, 3.15, 0.170, 458, 418, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
501, d3tikD1, 0.8417, 3.01, 0.189, 443, 419, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
502, p4xrzA_, 0.8415, 2.90, 0.188, 446, 415, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
503, d2nnhA_, 0.8411, 2.91, 0.187, 446, 416, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
504, d3ua5A1, 0.8409, 2.91, 0.190, 439, 416, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
505, d2nnjA_, 0.8409, 3.23, 0.173, 452, 421, CYP2C8DH COMPLEXED WITH FELODIPINE
506, d1pq2B_, 0.8403, 2.80, 0.184, 446, 412, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
507, d2nniA_, 0.8401, 3.33, 0.209, 464, 425, CYP2C8DH COMPLEXED WITH MONTELUKAST
508, d2wx2A_, 0.8397, 3.33, 0.209, 464, 425, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
509, d4uqhA1, 0.8394, 3.32, 0.181, 464, 426, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(34-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
510, d4bmmC1, 0.8394, 3.32, 0.181, 464, 426, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
511, d4uvrA1, 0.8391, 3.23, 0.178, 461, 421, BINDING MODE SELECTIVITY AND POTENCY OF N-INDOLYL- OXOPYRIDINYL-4-AMINO-PROPANYL-BASED INHIBITORS TARGETING TRYPANOSOMA CRUZI CYP51
512, d2nnhB_, 0.8391, 3.26, 0.210, 463, 423, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
513, p4wntA_, 0.8388, 3.30, 0.185, 471, 428, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
514, d4by0B1, 0.8388, 3.23, 0.211, 462, 422, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
515, d4i8vD_, 0.8387, 2.92, 0.181, 443, 414, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
516, d4ejhG_, 0.8387, 3.29, 0.215, 462, 424, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
517, d4by0A1, 0.8386, 2.97, 0.187, 440, 416, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
518, d1pq2A_, 0.8385, 2.97, 0.183, 446, 416, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
519, d3ua5B1, 0.8384, 3.10, 0.168, 457, 416, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
520, p2hi4A_, 0.8382, 3.29, 0.184, 463, 424, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 1A2 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
521, p4xryB_, 0.8380, 3.37, 0.178, 464, 426, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
522, d4i8vC_, 0.8375, 3.31, 0.186, 463, 424, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
523, p5e0eA_, 0.8372, 3.34, 0.184, 463, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B37 FROM DESERT WOODRAT IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
524, d4gqsA1, 0.8372, 3.31, 0.186, 463, 424, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
525, d4ejhH_, 0.8372, 2.96, 0.181, 441, 415, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
526, d4i8vA_, 0.8371, 2.88, 0.182, 439, 412, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
527, p4wnvC_, 0.8368, 2.98, 0.188, 438, 415, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
528, d4ejgG_, 0.8353, 2.86, 0.185, 436, 411, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
529, p5vbuA_, 0.8348, 3.36, 0.181, 463, 425, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
530, d1dt6A1, 0.8348, 3.15, 0.168, 457, 416, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2C5
531, d2wx2B1, 0.8345, 2.98, 0.193, 440, 415, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
532, d4gqsB1, 0.8344, 3.28, 0.190, 467, 426, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
533, p5vbuC_, 0.8339, 3.38, 0.198, 463, 425, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
534, d2p85B_, 0.8337, 3.03, 0.190, 439, 415, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
535, d4y8wA1, 0.8336, 3.30, 0.185, 463, 422, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
536, d4ejgH_, 0.8331, 3.33, 0.177, 461, 424, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
537, p3el3A_, 0.8329, 3.43, 0.195, 480, 430, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
538, d4nz2B1, 0.8328, 3.43, 0.195, 480, 430, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
539, p5vbuB_, 0.8325, 3.16, 0.173, 455, 416, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
540, d4nz2A1, 0.8324, 3.34, 0.185, 468, 427, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
541, d2pg7B1, 0.8324, 3.31, 0.185, 463, 421, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
542, p4wnvB_, 0.8322, 3.31, 0.191, 461, 423, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
543, p4wnuC_, 0.8322, 3.30, 0.197, 459, 422, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
544, p3tbgB_, 0.8321, 3.49, 0.186, 477, 430, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
545, p4wnuA_, 0.8320, 3.13, 0.171, 454, 414, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
546, d1suoA1, 0.8318, 3.38, 0.196, 463, 424, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 WITH BOUND 4-(4- CHLOROPHENYL)IMIDAZOLE
547, d1og5A_, 0.8318, 3.16, 0.203, 442, 414, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
548, d4y8wC1, 0.8317, 3.24, 0.177, 447, 418, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
549, d1og2B_, 0.8317, 3.10, 0.182, 440, 417, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
550, p3danA_, 0.8316, 3.33, 0.187, 455, 423, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
551, p5tfuB_, 0.8315, 3.16, 0.203, 442, 414, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
552, p3tdaB_, 0.8315, 3.49, 0.195, 464, 426, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
553, d2fdwB1, 0.8315, 3.03, 0.202, 439, 411, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
554, d1z11B1, 0.8315, 3.26, 0.193, 458, 420, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
555, p6chiB_, 0.8312, 2.75, 0.204, 417, 406, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
556, p3tbgD_, 0.8311, 2.75, 0.204, 417, 406, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
557, p6chiA_, 0.8309, 3.33, 0.195, 462, 420, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
558, d1og5B_, 0.8309, 3.15, 0.203, 441, 413, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
559, d3ebsB1, 0.8308, 3.36, 0.197, 462, 421, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
560, p6chiC_, 0.8307, 3.51, 0.193, 463, 425, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
561, p4xrzC_, 0.8307, 3.10, 0.175, 455, 411, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
562, d2pg6B1, 0.8307, 3.09, 0.170, 452, 411, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
563, p6cizB_, 0.8306, 3.13, 0.175, 456, 412, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
564, p6cizA_, 0.8306, 3.05, 0.168, 449, 410, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
565, p3tdaD_, 0.8306, 3.45, 0.172, 464, 424, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
566, d5xxiA_, 0.8305, 3.31, 0.188, 461, 420, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
567, p4wntB_, 0.8305, 3.17, 0.201, 441, 413, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
568, d3tmzA1, 0.8305, 3.32, 0.188, 461, 420, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH AMLODIPINE
569, d5x24A_, 0.8304, 3.25, 0.134, 473, 419, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT I359L (*3) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
570, p5iuzB_, 0.8304, 3.25, 0.134, 473, 419, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
571, d5x23A_, 0.8303, 3.13, 0.170, 451, 412, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT A477T (*30) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
572, d3ibdA1, 0.8303, 3.17, 0.175, 456, 412, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2B6 GENETIC VARIANT IN COMPLEX WITH THE INHIBITOR 4-(4-CHLOROPHENYL)IMIDAZOLE
573, p6cizC_, 0.8302, 3.52, 0.195, 463, 425, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
574, d3kswA_, 0.8301, 3.51, 0.195, 463, 425, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH AN INHIBITOR VNF ((4-(4- CHLOROPHENYL)-N-[2-(1H-IMIDAZOL-1-YL)-1-PHENYLETHYL]BENZAMIDE)
575, p3damA_, 0.8299, 3.18, 0.219, 457, 416, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
576, d2fdyC_, 0.8299, 3.15, 0.175, 456, 412, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
577, p3dbmA_, 0.8298, 3.20, 0.226, 455, 416, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
578, d4gqsC1, 0.8297, 3.32, 0.190, 461, 420, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
579, p5irvC_, 0.8295, 3.58, 0.195, 464, 426, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
580, p4xrzD_, 0.8295, 3.23, 0.221, 465, 417, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
581, d2pg5C_, 0.8293, 3.22, 0.171, 455, 414, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
582, d2fdwC_, 0.8293, 3.51, 0.196, 463, 424, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
583, d2fdvC_, 0.8293, 3.19, 0.219, 458, 416, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
584, d2fduC_, 0.8292, 3.19, 0.224, 457, 416, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
585, d4y8wB1, 0.8291, 3.18, 0.180, 456, 412, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
586, p4nkvB_, 0.8291, 3.52, 0.192, 463, 427, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
587, d2pg6C_, 0.8291, 3.15, 0.175, 455, 411, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
588, d2fduB_, 0.8291, 3.47, 0.173, 462, 423, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
589, d1z10B1, 0.8291, 3.45, 0.192, 463, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
590, p5uysB_, 0.8290, 3.59, 0.173, 464, 427, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
591, p5uysA_, 0.8290, 3.49, 0.195, 463, 426, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
592, p5tfuA_, 0.8290, 3.48, 0.174, 462, 425, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
593, p3cliA_, 0.8290, 3.24, 0.221, 464, 417, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
594, d1z11C_, 0.8290, 3.05, 0.164, 444, 414, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
595, p3dsjA_, 0.8289, 3.19, 0.137, 467, 417, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
596, p3dsiA_, 0.8289, 3.51, 0.195, 464, 425, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
597, d1z10C_, 0.8289, 3.21, 0.141, 467, 417, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
598, d1og2A_, 0.8289, 3.42, 0.189, 461, 424, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
599, p6cizD_, 0.8288, 3.21, 0.221, 464, 416, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
600, p4wnvD_, 0.8288, 3.21, 0.221, 464, 416, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
601, p2rcmA_, 0.8288, 3.24, 0.171, 455, 414, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
602, d2pg5B1, 0.8288, 3.50, 0.195, 463, 425, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
603, p5irvD_, 0.8286, 3.54, 0.195, 464, 426, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
604, p2rclA_, 0.8286, 3.53, 0.195, 464, 426, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
605, p2rchA_, 0.8286, 3.54, 0.195, 464, 426, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
606, p5tftD_, 0.8285, 3.15, 0.204, 439, 411, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
607, d2fdvB1, 0.8285, 3.22, 0.219, 456, 416, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
608, p5uysC_, 0.8284, 3.55, 0.195, 464, 426, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
609, p5uysD_, 0.8281, 3.55, 0.195, 463, 425, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
610, p3dskA_, 0.8281, 3.55, 0.195, 463, 425, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
611, p4nkvA_, 0.8280, 3.18, 0.219, 459, 415, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
612, d3t3rD1, 0.8280, 3.19, 0.219, 460, 415, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
613, p3me6B_, 0.8280, 3.11, 0.171, 451, 410, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
614, p5irvB_, 0.8279, 3.22, 0.129, 465, 417, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
615, p3swzA_, 0.8279, 3.49, 0.191, 464, 425, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
616, p5irqB_, 0.8278, 3.22, 0.129, 465, 417, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
617, p4nkvC_, 0.8278, 3.22, 0.129, 466, 417, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
618, d3t3qC_, 0.8278, 3.54, 0.195, 464, 426, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
619, d3qz1A_, 0.8278, 3.35, 0.189, 461, 419, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
620, p6chiD_, 0.8277, 3.27, 0.221, 457, 417, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
621, p3rukD_, 0.8277, 3.09, 0.176, 453, 409, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
622, p3me6C_, 0.8277, 3.22, 0.129, 465, 417, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
623, p3me6D_, 0.8274, 3.56, 0.195, 463, 425, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
624, d2pg7C_, 0.8274, 3.21, 0.221, 461, 416, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
625, p5irqA_, 0.8273, 3.23, 0.129, 465, 417, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
626, p4xryD_, 0.8273, 3.22, 0.129, 465, 417, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
627, p3me6A_, 0.8273, 3.11, 0.178, 453, 409, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
628, d3kw4A1, 0.8273, 3.55, 0.195, 463, 425, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG TICLOPIDINE
629, p5iuzA_, 0.8272, 3.21, 0.219, 462, 415, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
630, p3tk3D_, 0.8272, 3.16, 0.214, 462, 415, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
631, d3ebsC_, 0.8272, 3.23, 0.129, 466, 417, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
632, p5iutA_, 0.8271, 3.21, 0.219, 455, 415, STRUCTURE OF P450 2B4 F202W MUTANT
633, p5irvA_, 0.8271, 3.52, 0.189, 463, 423, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
634, p4wnuB_, 0.8271, 3.53, 0.172, 465, 425, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
635, p5irqC_, 0.8270, 3.20, 0.219, 460, 415, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
636, p4nkwA_, 0.8270, 3.23, 0.224, 460, 416, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
637, p3tk3C_, 0.8270, 3.22, 0.219, 456, 415, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
638, p3tk3A_, 0.8269, 3.21, 0.219, 460, 415, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
639, p3tk3B_, 0.8267, 3.55, 0.196, 463, 424, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
640, d3uasA1, 0.8266, 3.15, 0.174, 445, 413, CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR 9-ETHYNYLPHENANTHRENE
641, d3t3qD_, 0.8266, 3.15, 0.174, 445, 413, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
642, p4nkwB_, 0.8265, 3.29, 0.221, 456, 417, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
643, d3t3rA_, 0.8265, 3.18, 0.214, 462, 415, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
644, p5tfuD_, 0.8264, 3.53, 0.172, 465, 425, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
645, d1z11A1, 0.8264, 3.53, 0.172, 465, 425, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
646, p6cirC_, 0.8263, 3.58, 0.192, 464, 426, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
647, p5tfuC_, 0.8262, 3.22, 0.219, 455, 415, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
648, p4wnuD_, 0.8262, 3.22, 0.172, 452, 412, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
649, d2fduD_, 0.8262, 3.53, 0.172, 465, 425, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
650, p5em4B_, 0.8261, 3.58, 0.171, 465, 426, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
651, p5em4A_, 0.8261, 3.54, 0.172, 459, 424, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
652, p4nkxB_, 0.8261, 3.54, 0.172, 465, 425, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
653, d2fdvA_, 0.8261, 3.59, 0.195, 464, 426, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
654, d2fduA_, 0.8261, 3.52, 0.170, 460, 424, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
655, d1z11D_, 0.8260, 3.21, 0.219, 460, 415, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
656, p6cirA_, 0.8259, 3.12, 0.174, 453, 409, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
657, p4nkxA_, 0.8259, 3.24, 0.219, 461, 415, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
658, p6cirD_, 0.8258, 3.24, 0.219, 453, 415, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
659, p4nkyC_, 0.8256, 3.63, 0.173, 465, 427, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
660, p2f9qC_, 0.8255, 3.62, 0.173, 465, 427, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
661, p3swzC_, 0.8254, 3.58, 0.174, 465, 426, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
662, d3mvrA1, 0.8254, 3.44, 0.173, 460, 422, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
663, d2fdwD_, 0.8254, 3.54, 0.196, 463, 424, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
664, d1z10D_, 0.8254, 3.23, 0.222, 453, 415, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
665, p4nkyA_, 0.8253, 3.54, 0.195, 463, 425, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
666, p4h1nA_, 0.8251, 3.26, 0.172, 453, 413, CRYSTAL STRUCTURE OF P450 2B4 F297A MUTANT IN COMPLEX WITH ANTI- PLATELET DRUG CLOPIDOGREL
667, d3t3qB_, 0.8251, 3.63, 0.201, 465, 427, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
668, d3mvrB1, 0.8251, 3.22, 0.217, 461, 415, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
669, d2pg5D_, 0.8251, 3.11, 0.179, 450, 408, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
670, d4ejjC_, 0.8249, 3.12, 0.176, 450, 408, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
671, d1z10A_, 0.8249, 3.61, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
672, p6cirB_, 0.8248, 3.62, 0.171, 459, 426, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
673, d4jltA1, 0.8247, 3.62, 0.171, 460, 426, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH PAROXETINE
674, p2f9qA_, 0.8247, 3.23, 0.219, 457, 415, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
675, d2pg6D_, 0.8246, 3.63, 0.201, 465, 427, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
676, p3rukB_, 0.8245, 3.63, 0.201, 465, 427, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
677, p4nkyB_, 0.8244, 3.60, 0.195, 464, 426, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
678, d4r21B_, 0.8243, 3.26, 0.217, 455, 415, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
679, p4nkwD_, 0.8243, 3.13, 0.214, 455, 412, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
680, d2pg7A_, 0.8243, 3.21, 0.217, 459, 415, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
681, d2pg5A_, 0.8242, 3.18, 0.217, 456, 414, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
682, p4nkwC_, 0.8241, 3.20, 0.178, 454, 410, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
683, p5k7kA_, 0.8239, 3.25, 0.217, 459, 415, DESIGN AND OPTIMIZATION OF BIARYL ETHER ARYL SULFONAMIDES AS SELECTIVE INHIBITORS OF NAV1.7: DISCOVERY OF CLINICAL CANDIDATE PF-05089771
684, p4nkxC_, 0.8239, 3.64, 0.171, 462, 426, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
685, d4ejjB_, 0.8239, 3.62, 0.195, 464, 426, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
686, d2pg6A_, 0.8239, 3.62, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
687, p4nkvD_, 0.8238, 3.27, 0.222, 451, 415, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
688, d2fdwA_, 0.8238, 3.61, 0.174, 459, 425, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
689, p3rukC_, 0.8237, 3.60, 0.195, 463, 425, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
690, d3ebsA_, 0.8237, 3.65, 0.171, 462, 426, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
691, p5wbgB_, 0.8236, 3.62, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
692, d4ruiF1, 0.8236, 3.62, 0.195, 464, 426, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
693, d4ejjA_, 0.8236, 3.65, 0.201, 465, 427, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
694, d1r9oA1, 0.8236, 3.65, 0.201, 465, 427, CRYSTAL STRUCTURE OF P4502C9 WITH FLURBIPROFEN BOUND
695, d4ruiD1, 0.8235, 3.26, 0.217, 455, 415, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
696, d4r21A_, 0.8235, 3.55, 0.173, 457, 423, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
697, d3ebsD_, 0.8235, 3.21, 0.178, 454, 410, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
698, p3rukA_, 0.8234, 3.64, 0.195, 464, 426, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
699, d4ruiE1, 0.8233, 3.28, 0.217, 454, 415, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
700, p4nkzB_, 0.8233, 3.18, 0.216, 453, 412, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
701, d2fdvD_, 0.8233, 2.92, 0.223, 423, 403, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
702, d4ejhA_, 0.8232, 2.92, 0.223, 423, 403, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
703, p3swzB_, 0.8232, 3.27, 0.219, 456, 415, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
704, d2fdyB1, 0.8232, 3.66, 0.192, 464, 426, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
705, d3qz1C_, 0.8231, 3.65, 0.195, 464, 426, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
706, d2vkuA_, 0.8231, 3.27, 0.219, 456, 415, 44 -DIHYDROXYBENZOPHENONE MIMICS STEROL SUBSTRATE IN THE BINDING SITE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) IN THE X-RAY STRUCTURE OF THE COMPLEX
707, p5irqD_, 0.8230, 3.47, 0.189, 455, 419, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
708, d4ejjD_, 0.8230, 3.27, 0.217, 458, 415, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
709, d4ruiC_, 0.8229, 3.64, 0.195, 464, 426, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
710, d4ruiB1, 0.8229, 3.68, 0.201, 465, 427, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
711, d2pg7D_, 0.8229, 3.29, 0.217, 454, 415, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
712, p5wbgF_, 0.8228, 3.68, 0.201, 465, 427, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
713, p5wbgC_, 0.8228, 3.23, 0.214, 461, 415, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
714, d4ruiA_, 0.8228, 3.67, 0.201, 465, 427, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
715, p3swzD_, 0.8228, 3.63, 0.174, 464, 426, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
716, d3t3sB_, 0.8226, 3.64, 0.195, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
717, p3r1aA_, 0.8226, 3.64, 0.195, 465, 426, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
718, d4ejhC_, 0.8225, 3.36, 0.187, 453, 416, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
719, p4nkzA_, 0.8224, 3.59, 0.193, 464, 425, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
720, d4ejgE1, 0.8224, 2.89, 0.221, 422, 402, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
721, d4ejgC_, 0.8224, 3.65, 0.195, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
722, d3t3rB_, 0.8224, 3.31, 0.219, 453, 415, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
723, d4ejgA_, 0.8223, 3.64, 0.195, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
724, d4ejgD1, 0.8222, 3.19, 0.218, 450, 413, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
725, d2q6nB1, 0.8222, 3.66, 0.195, 464, 426, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
726, d3qz1B_, 0.8221, 3.63, 0.197, 464, 426, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
727, d3t3qA_, 0.8220, 3.29, 0.217, 454, 415, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
728, d2q6nG1, 0.8218, 3.59, 0.191, 463, 423, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
729, d3t3sD_, 0.8217, 3.10, 0.198, 437, 409, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
730, d3t3rC_, 0.8217, 3.18, 0.202, 444, 411, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
731, d3pm0A_, 0.8217, 3.31, 0.217, 454, 415, STRUCTURAL CHARACTERIZATION OF THE COMPLEX BETWEEN ALPHA- NAPHTHOFLAVONE AND HUMAN CYTOCHROME P450 1B1 (CYP1B1)
732, d2fdyA_, 0.8217, 3.65, 0.195, 464, 426, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
733, p5wbgD_, 0.8216, 3.65, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
734, p5tftC_, 0.8216, 3.69, 0.199, 464, 427, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
735, d4ejhD_, 0.8216, 3.65, 0.192, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
736, d4ejgB_, 0.8216, 3.64, 0.176, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
737, p4nkxD_, 0.8215, 3.64, 0.174, 464, 426, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
738, d4ejhB_, 0.8215, 3.63, 0.197, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
739, p5wbgA_, 0.8214, 3.35, 0.216, 455, 416, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
740, d4ejhE_, 0.8213, 3.66, 0.200, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
741, p4nkyD_, 0.8212, 3.69, 0.171, 465, 427, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
742, p3r1aD_, 0.8212, 3.67, 0.204, 464, 427, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
743, p5e58D_, 0.8211, 3.24, 0.217, 452, 414, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
744, d3t3sC_, 0.8211, 3.63, 0.197, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
745, p5wbgE_, 0.8209, 3.64, 0.200, 464, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
746, p3r1aC_, 0.8209, 3.62, 0.195, 463, 425, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
747, d2fdyD_, 0.8209, 3.66, 0.200, 464, 426, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
748, p4nkzC_, 0.8208, 3.64, 0.197, 464, 426, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
749, d4ejgF1, 0.8208, 3.63, 0.174, 464, 425, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
750, d3t3sA_, 0.8208, 3.05, 0.194, 436, 408, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
751, p5e58A_, 0.8206, 3.64, 0.195, 463, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
752, d5a5iA1, 0.8205, 3.64, 0.174, 464, 425, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
753, p4xryC_, 0.8205, 3.71, 0.204, 464, 427, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
754, d5a5jA1, 0.8204, 3.64, 0.195, 463, 425, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
755, d4ejhF_, 0.8204, 3.15, 0.177, 459, 412, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
756, p3r1aG_, 0.8203, 3.15, 0.177, 459, 412, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
757, d2p85E_, 0.8203, 3.67, 0.195, 465, 426, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
758, p2f9qB_, 0.8203, 3.61, 0.176, 464, 425, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
759, d3t3sH_, 0.8201, 3.08, 0.178, 447, 405, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
760, p5e58C_, 0.8199, 3.69, 0.204, 464, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
761, p4nkzD_, 0.8198, 3.66, 0.200, 464, 426, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
762, d3qu8A1, 0.8197, 3.30, 0.217, 457, 415, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
763, p2f9qD_, 0.8195, 3.69, 0.201, 464, 427, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
764, d3t3sG_, 0.8193, 3.67, 0.174, 463, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
765, d3qz1D_, 0.8192, 3.70, 0.201, 464, 427, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
766, d3t3sF_, 0.8190, 3.33, 0.217, 454, 415, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
767, p3kohB_, 0.8189, 3.74, 0.176, 465, 427, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
768, d2q6nF1, 0.8188, 3.73, 0.194, 463, 427, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
769, d4ejiA_, 0.8187, 3.61, 0.198, 464, 425, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH TWO MOLECULES OF 4- (METHYLNITROSAMINO)-1-(3-PURIDYL)-1-BUTANONE
770, d3b6hB1, 0.8186, 3.68, 0.171, 463, 426, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
771, p4zv8A_, 0.8184, 3.72, 0.169, 465, 427, STRUCTURE OF CYP2B6 (Y226H/K262R) WITH ADDITIONAL MUTATION Y244W IN COMPLEX WITH ALPHA-PINENE
772, p4mgjA_, 0.8184, 3.69, 0.195, 464, 426, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 F429H IN COMPLEX WITH 4-CPI
773, d2q6nC1, 0.8183, 3.27, 0.220, 453, 414, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
774, p3r1aF_, 0.8182, 3.67, 0.197, 464, 426, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
775, p2rcmB_, 0.8182, 3.67, 0.198, 464, 425, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
776, d3qu8C1, 0.8181, 3.74, 0.194, 464, 427, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
777, p5e58E_, 0.8178, 3.32, 0.186, 450, 413, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
778, p2rclB_, 0.8178, 3.20, 0.172, 446, 408, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
779, p3kohA_, 0.8176, 3.39, 0.186, 452, 415, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
780, p3cliB_, 0.8176, 3.69, 0.200, 464, 426, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
781, d2p85F_, 0.8176, 3.73, 0.171, 465, 427, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
782, d2p85D_, 0.8176, 3.67, 0.195, 464, 425, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
783, d2p85A_, 0.8176, 3.17, 0.179, 451, 407, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
784, p5uecA_, 0.8174, 3.60, 0.196, 464, 423, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH MYRTENYL BROMIDE.
785, p3r1aH_, 0.8173, 3.78, 0.194, 465, 428, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
786, p3e4eB_, 0.8173, 3.34, 0.217, 454, 415, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
787, p3r1aE_, 0.8172, 3.64, 0.174, 461, 425, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
788, p3e4eA_, 0.8172, 3.20, 0.179, 451, 407, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
789, p3dsjB_, 0.8170, 3.70, 0.200, 464, 426, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
790, p3lc4A_, 0.8169, 3.04, 0.192, 434, 406, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
791, p3dsiB_, 0.8169, 3.64, 0.198, 464, 424, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
792, p3e6iB_, 0.8168, 3.64, 0.179, 463, 425, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
793, d2q6nA1, 0.8167, 3.81, 0.176, 464, 427, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
794, p3e6iA_, 0.8166, 3.68, 0.200, 464, 425, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
795, p2rchB_, 0.8166, 3.41, 0.170, 469, 418, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
796, d2p85C_, 0.8165, 3.79, 0.175, 465, 428, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
797, d4rqlB1, 0.8164, 3.47, 0.173, 452, 416, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
798, p5udaA_, 0.8160, 3.79, 0.176, 464, 427, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
799, p5uapB_, 0.8160, 3.80, 0.173, 465, 428, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
800, p5e58B_, 0.8160, 3.37, 0.130, 465, 414, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
801, d4rqlA1, 0.8160, 3.68, 0.174, 461, 425, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
802, d4i91A1, 0.8160, 3.79, 0.194, 462, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH ALPHA-PINENE.
803, p3dskB_, 0.8160, 3.32, 0.136, 465, 413, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
804, d4rrtA_, 0.8157, 3.72, 0.185, 463, 427, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
805, d3qu8B1, 0.8156, 3.34, 0.136, 465, 413, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
806, p3gphB_, 0.8156, 3.73, 0.204, 464, 426, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
807, p3t3zA_, 0.8154, 3.74, 0.202, 464, 426, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
808, d3qu8E1, 0.8154, 3.69, 0.198, 464, 425, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
809, p5ufgA_, 0.8153, 3.75, 0.173, 465, 427, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R/I114V) IN COMPLEX WITH MYRTENYL BROMIDE
810, d4rrtB_, 0.8152, 3.76, 0.178, 464, 426, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
811, p3r1aB_, 0.8152, 3.67, 0.188, 461, 425, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
812, p5uapA_, 0.8151, 3.83, 0.175, 465, 428, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
813, p3t3zB_, 0.8151, 3.67, 0.188, 461, 425, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
814, p3gphA_, 0.8151, 3.35, 0.136, 465, 413, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
815, p3lc4B_, 0.8150, 3.62, 0.189, 460, 423, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
816, d3qoaA1, 0.8148, 3.35, 0.136, 465, 413, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-BENZYLPYRIDINE.
817, d2q6nD1, 0.8147, 3.69, 0.188, 461, 425, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
818, d2q6nE1, 0.8146, 3.69, 0.172, 464, 424, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
819, d3qu8D_, 0.8145, 3.70, 0.188, 462, 425, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
820, d3t3sE_, 0.8144, 3.36, 0.136, 465, 413, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
821, p5udaB_, 0.8136, 3.78, 0.204, 464, 427, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
822, d4gqsD1, 0.8136, 3.74, 0.176, 464, 426, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
823, d2iagB1, 0.8135, 3.76, 0.176, 461, 426, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
824, d4r20B1, 0.8133, 3.80, 0.176, 463, 427, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
825, p3t3zC_, 0.8132, 3.68, 0.194, 458, 423, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
826, p3t3zD_, 0.8128, 3.80, 0.173, 464, 427, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
827, d2iagA1, 0.8128, 3.80, 0.173, 464, 427, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
828, d3b6hA1, 0.8127, 3.37, 0.136, 465, 413, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
829, p5e58F_, 0.8104, 3.72, 0.176, 461, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
830, d5w0cA1, 0.8100, 3.62, 0.175, 458, 422, CYTOCHROME P450 (CYP) 2C9 TCA007 INHIBITOR COMPLEX
831, d1e9xA_, 0.8100, 3.65, 0.186, 461, 424, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE
832, d3v8dA1, 0.8098, 3.70, 0.187, 464, 427, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
833, d3sn5A1, 0.8095, 3.63, 0.178, 458, 422, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
834, d2w0bA_, 0.8086, 3.75, 0.176, 464, 426, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR 3-{[(4- METHYLPHENYL)SULFONYL]AMINO}PROPYL PYRIDIN-4-YLCARBAMATE
835, d1ea1A_, 0.8083, 3.78, 0.176, 461, 426, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE
836, d4r20A_, 0.8078, 3.79, 0.173, 465, 427, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
837, d3daxA1, 0.8075, 3.81, 0.176, 464, 427, CRYSTAL STRUCTURE OF HUMAN CYP7A1
838, d3sn5B_, 0.8074, 3.71, 0.187, 464, 427, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
839, d3daxB1, 0.8054, 3.67, 0.186, 461, 424, CRYSTAL STRUCTURE OF HUMAN CYP7A1
840, d3qu8F_, 0.8050, 3.61, 0.190, 459, 422, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
841, d5m0pB_, 0.8041, 3.72, 0.177, 459, 424, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
842, d5m0pA1, 0.8040, 3.73, 0.172, 464, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
843, d5m0oC1, 0.8029, 3.85, 0.173, 464, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
844, d3v8dB1, 0.8029, 3.63, 0.175, 458, 422, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
845, d2bz9B_, 0.8024, 3.68, 0.200, 464, 424, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
846, d1x8vA_, 0.8021, 3.77, 0.176, 460, 425, ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- DEMETHYLASE (CYP51)
847, d5m0nA1, 0.8020, 3.45, 0.192, 451, 416, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET IN COMPLEX WITH FORMATE
848, d1u13A_, 0.8020, 3.43, 0.166, 466, 416, CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T/C442A-TRIPLE MUTANT OF CYP51 FROM MYCOBACTERIUM TUBERCULOSIS
849, d1h5zA_, 0.7971, 2.83, 0.230, 413, 396, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE
850, d5m0oA_, 0.7965, 3.78, 0.183, 464, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
851, d4l54A_, 0.7962, 3.74, 0.185, 464, 427, STRUCTURE OF CYTOCHROME P450 OLET LIGAND-FREE
852, d4l40A_, 0.7957, 3.59, 0.171, 470, 421, STRUCTURE OF THE P450 OLET WITH A C20 FATTY ACID SUBSTRATE BOUND
853, d2bz9A_, 0.7957, 3.59, 0.171, 470, 421, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
854, d2w09A_, 0.7912, 3.53, 0.172, 468, 418, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR CIS-4- METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4- YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE
855, p4r1zA_, 0.7911, 3.78, 0.201, 457, 423, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
856, d5yhjB_, 0.7899, 3.27, 0.190, 463, 406, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
857, p3qi8A1, 0.7890, 3.36, 0.196, 449, 408, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
858, d2w0aA_, 0.7884, 3.36, 0.196, 449, 408, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR N-[(1S)-2-METHYL-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL] CYCLOHEXANECARBOXAMIDE
859, p4r1zB_, 0.7878, 3.83, 0.161, 476, 422, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
860, d2zqjB_, 0.7870, 3.83, 0.161, 476, 422, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
861, d2zqxC_, 0.7865, 3.62, 0.157, 467, 420, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
862, d2zqjC_, 0.7865, 3.36, 0.199, 440, 407, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
863, d2zqjA_, 0.7858, 3.46, 0.196, 447, 409, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
864, d2zqxB_, 0.7856, 2.83, 0.226, 406, 393, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
865, d1n97A_, 0.7856, 3.69, 0.156, 469, 417, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
866, d2zqxA_, 0.7855, 3.53, 0.156, 466, 416, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
867, d1izoB_, 0.7853, 3.72, 0.156, 469, 417, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
868, d1izoC_, 0.7845, 3.64, 0.180, 453, 417, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
869, d1izoA_, 0.7842, 3.20, 0.134, 421, 404, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
870, d5yhjA_, 0.7837, 3.22, 0.133, 422, 405, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
871, d3g5nA1, 0.7831, 3.24, 0.133, 419, 405, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
872, d3b99A_, 0.7830, 3.86, 0.157, 466, 420, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
873, d3b98A_, 0.7827, 3.16, 0.195, 432, 401, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
874, p5omsA_, 0.7818, 3.23, 0.197, 429, 402, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAETHOL. 
875, p5omrA_, 0.7815, 3.26, 0.136, 422, 405, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH VANILLIN. 
876, d2ci0A_, 0.7812, 3.26, 0.136, 422, 405, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
877, d3g5nC1, 0.7806, 3.22, 0.190, 433, 401, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
878, d3g5nB1, 0.7806, 3.34, 0.195, 434, 401, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
879, d2cibA_, 0.7803, 3.26, 0.134, 419, 402, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
880, d3g5nD1, 0.7801, 3.26, 0.137, 419, 402, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
881, d1n97B_, 0.7784, 3.26, 0.137, 419, 402, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
882, d1po5A1, 0.7778, 3.14, 0.196, 429, 397, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4
883, d3vooA_, 0.7748, 3.21, 0.199, 421, 396, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245E
884, d3tktA_, 0.7748, 2.96, 0.210, 417, 386, CRYSTAL STRUCTURE OF CYP108D1 FROM NOVOSPHINGOBIUM AROMATICIVORANS DSM12444
885, d3vnoA_, 0.7745, 3.18, 0.126, 411, 397, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT R241E
886, d3vm4A_, 0.7744, 3.18, 0.126, 411, 397, CYTOCHROME P450SP ALPHA (CYP152B1) IN COMPLEX WITH (R)-IBUPROPHEN
887, d3awqA_, 0.7738, 0.66, 0.960, 352, 349, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT L78F
888, d3awmA_, 0.7735, 3.23, 0.192, 424, 395, CYTOCHROME P450SP ALPHA (CYP152B1) WILD-TYPE WITH PALMITIC ACID
889, d3vtjA_, 0.7732, 2.93, 0.211, 411, 384, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245H
890, d2wm4A_, 0.7730, 3.20, 0.151, 411, 397, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124 IN COMPLEX WITH PHYTANIC ACID
891, d3awpA_, 0.7728, 3.21, 0.156, 411, 397, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT F288G
892, d2xkrA_, 0.7726, 3.22, 0.156, 411, 397, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP142: A NOVEL CHOLESTEROL OXIDASE
893, d1cptA_, 0.7715, 3.22, 0.151, 411, 397, CRYSTAL STRUCTURE AND REFINEMENT OF CYTOCHROME P450-TERP AT 2.3 ANGSTROMS RESOLUTION
894, d5fygB_, 0.7680, 3.22, 0.151, 411, 397, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
895, p5ncbA_, 0.7676, 2.44, 0.241, 385, 374, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAIACOL. 
896, d2wm5A_, 0.7673, 2.44, 0.241, 385, 374, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124
897, d5fygA_, 0.7670, 3.22, 0.151, 411, 397, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
898, d1xqdA_, 0.7664, 3.22, 0.154, 411, 397, CRYSTAL STRUCTURE OF P450NOR COMPLEXED WITH 3- PYRIDINEALDEHYDE ADENINE DINUCLEOTIDE
899, d4triB_, 0.7656, 3.24, 0.156, 411, 397, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
900, d4ep6A_, 0.7653, 3.35, 0.151, 411, 398, CRYSTAL STRUCTURE OF THE XPLA HEME DOMAIN IN COMPLEX WITH IMIDAZOLE AND PEG
901, d4uaxA1, 0.7650, 3.35, 0.151, 411, 398, X-RAY CRYSTAL STRUCTURE OF LIGAND FREE CYP142A2 FROM MYCOBACTERIUM SMEGMATIS
902, d4jbtB_, 0.7650, 3.14, 0.127, 406, 393, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
903, d1egyA_, 0.7650, 3.88, 0.174, 454, 407, CYTOCHROME P450ERYF WITH 9-AMINOPHENANTHRENE BOUND
904, d5fyfA_, 0.7649, 3.63, 0.167, 445, 408, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
905, d4j6cB_, 0.7648, 3.62, 0.167, 446, 408, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
906, d4jbtA_, 0.7647, 3.62, 0.167, 446, 408, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
907, d1eh0A_, 0.7647, 2.93, 0.144, 403, 383,  
908, d1eupA_, 0.7646, 2.94, 0.144, 403, 383, X-RAY CRYSTAL STRUCTURE OF CYTOCHROME P450ERYF WITH ANDROSTENDIONE BOUND
909, d4j6cA_, 0.7645, 3.17, 0.195, 421, 390, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
910, p2wiyA_, 0.7642, 3.78, 0.171, 451, 404, CYTOCHROME P450 XPLA HEME DOMAIN P21212
911, d4j6dB_, 0.7641, 3.84, 0.173, 450, 405, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
912, d2yooC_, 0.7639, 3.18, 0.203, 419, 390, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
913, p6giiA_, 0.7638, 3.85, 0.173, 450, 405, THE CRYSTAL STRUCTURE OF TEPIDIPHILUS THERMOPHILUS P450 HEME DOMAIN 
914, d4j6dA_, 0.7636, 2.65, 0.241, 385, 374, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
915, d1oxaA_, 0.7635, 4.20, 0.169, 464, 413, CYTOCHROME P450 (DONOR:O2 OXIDOREDUCTASE)
916, d4triA1, 0.7634, 3.34, 0.132, 407, 394, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
917, p2wivB_, 0.7633, 3.12, 0.174, 411, 386, CYTOCHROME-P450 XPLA HEME DOMAIN P21
918, d1jinA_, 0.7632, 3.12, 0.174, 411, 386, P450ERYF/KETOCONAZOLE
919, d4j6bB_, 0.7628, 3.36, 0.129, 407, 394, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
920, d4j6bA_, 0.7628, 3.33, 0.132, 407, 393, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
921, d1jipA_, 0.7628, 3.34, 0.132, 407, 393, P450ERYF(A245S)/KETOCONAZOLE
922, d4pxhA_, 0.7627, 3.35, 0.132, 407, 393, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
923, d3zbyA1, 0.7627, 3.35, 0.132, 407, 393, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
924, d3zbyF1, 0.7626, 3.33, 0.130, 407, 393, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
925, d3zbyD1, 0.7626, 3.21, 0.160, 426, 387, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
926, d3zbyC1, 0.7625, 3.21, 0.160, 426, 387, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
927, d3zbyB1, 0.7625, 3.36, 0.132, 407, 393, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
928, p3r1bA1, 0.7625, 2.90, 0.171, 395, 381, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
929, d3zbyE1, 0.7623, 3.21, 0.182, 412, 385, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
930, p2wivA_, 0.7621, 3.21, 0.182, 412, 385, CYTOCHROME-P450 XPLA HEME DOMAIN P21
931, d4pxhE_, 0.7619, 3.23, 0.135, 419, 385, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
932, d2yooB_, 0.7619, 2.85, 0.141, 396, 375, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
933, d1jioA_, 0.7618, 3.53, 0.159, 425, 390, P450ERYF/6DEB
934, d1z8qA_, 0.7616, 3.31, 0.132, 422, 386, FERROUS DIOXYGEN COMPLEX OF THE A245T CYTOCHROME P450ERYF
935, d3a1lA_, 0.7615, 3.31, 0.132, 422, 386, CRYSTAL STRUCTURE OF 1111 -DICHLOROCHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
936, d1z8pA_, 0.7615, 3.02, 0.130, 399, 378, FERROUS DIOXYGEN COMPLEX OF THE A245S CYTOCHROME P450ERYF
937, d2bdmA2, 0.7612, 3.18, 0.154, 400, 384, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND BIFONAZOLE
938, d1z8oA_, 0.7612, 3.28, 0.148, 392, 384, FERROUS DIOXYGEN COMPLEX OF THE WILD-TYPE CYTOCHROME P450ERYF
939, d2yooA_, 0.7611, 3.20, 0.156, 399, 384, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
940, d2yooD_, 0.7610, 3.35, 0.153, 407, 385, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
941, d4pxhC_, 0.7605, 3.13, 0.152, 403, 382, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
942, d3p3xA_, 0.7605, 3.13, 0.152, 403, 382, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
943, d2x5wA_, 0.7595, 3.30, 0.132, 420, 385, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH SUBSTRATE CHOLEST-4-EN-3-ONE
944, d2z3uA_, 0.7593, 3.30, 0.151, 406, 384, CRYSTAL STRUCTURE OF CHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
945, d3b98B_, 0.7590, 3.35, 0.153, 407, 385, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
946, d3p3xB_, 0.7588, 3.08, 0.152, 403, 381, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
947, d2fr7A_, 0.7585, 3.14, 0.152, 403, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP199A2
948, d1wiyB_, 0.7583, 3.30, 0.154, 407, 384, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
949, d4mm0B_, 0.7577, 3.30, 0.154, 407, 384, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
950, d1qmqA_, 0.7577, 3.38, 0.145, 394, 386, OPTICAL DETECTION OF CYTOCHROME P450 BY SENSITIZER-LINKED SUBSTRATES
951, d4jx1F_, 0.7574, 3.38, 0.145, 394, 386, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
952, p4l0fA_, 0.7573, 3.32, 0.151, 406, 384, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (OPEN ACTIVE SITE)
953, d5gweC_, 0.7571, 3.07, 0.157, 395, 382, CYTOCHROME P450 CREJ
954, d1ulwA_, 0.7571, 3.63, 0.113, 416, 391, CRYSTAL STRUCTURE OF P450NOR SER73GLY/SER75GLY MUTANT
955, d4mm0A_, 0.7569, 3.34, 0.156, 406, 384, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
956, d1k2oB_, 0.7569, 3.14, 0.152, 403, 382, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
957, d4jx1B_, 0.7568, 3.04, 0.157, 397, 381, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
958, d3p3lB_, 0.7564, 3.24, 0.146, 391, 383, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
959, d4jx1A_, 0.7563, 3.16, 0.154, 403, 382, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
960, d4dnjA_, 0.7561, 3.25, 0.152, 405, 382, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A2
961, d3p3lA_, 0.7560, 3.32, 0.151, 405, 383, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
962, d1k2oA_, 0.7560, 3.20, 0.157, 403, 383, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
963, d4dxyA_, 0.7559, 3.60, 0.172, 417, 390, CRYSTAL STRUCTURES OF CYP101D2 Y96A MUTANT
964, d5gweA_, 0.7558, 3.25, 0.154, 400, 384, CYTOCHROME P450 CREJ
965, d3nc6B_, 0.7556, 3.25, 0.154, 400, 384, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
966, d4jwuA_, 0.7553, 3.25, 0.154, 400, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
967, d3p6sA_, 0.7551, 3.25, 0.154, 400, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
968, d5xjnA_, 0.7550, 3.26, 0.154, 400, 384, CYTOCHROME P450 CREJ IN COMPLEX WITH (4-ETHYLPHENYL) DIHYDROGEN PHOSPHATE
969, d4egmB_, 0.7549, 3.25, 0.154, 400, 384, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
970, d1gwiA_, 0.7549, 3.61, 0.189, 427, 392, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
971, d1rf9A_, 0.7548, 3.26, 0.154, 400, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-4-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-BUTYL-AMIDE)
972, d1romA_, 0.7546, 3.25, 0.146, 391, 383, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM
973, d5ikiB_, 0.7543, 3.52, 0.170, 407, 388, CYP106A2 WITH SUBSTRATE ABIETIC ACID
974, d1odoA_, 0.7543, 3.06, 0.157, 395, 381, 1.85 A STRUCTURE OF CYP154A1 FROM STREPTOMYCES COELICOLOR A3(2)
975, d5fyfB_, 0.7540, 3.32, 0.154, 403, 384, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
976, d3bujA1, 0.7540, 3.17, 0.157, 403, 382, CRYSTAL STRUCTURE OF CALO2
977, d2romA_, 0.7540, 3.31, 0.185, 411, 383, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM COMPLEX WITH CARBON MONOXIDE
978, d5gweD_, 0.7539, 3.17, 0.154, 403, 382, CYTOCHROME P450 CREJ
979, d3p6uA_, 0.7539, 4.16, 0.173, 464, 405, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C6-DANS
980, d3nv6A_, 0.7538, 3.14, 0.155, 402, 381, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D2
981, d5gxgA_, 0.7537, 3.07, 0.157, 396, 381, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
982, p5kdbA_, 0.7536, 3.04, 0.158, 394, 380, THE CRYSTAL STRUCTURE OF 4-ISOPROPYLBENZOATE-BOUND CYP199A4
983, d4egmA_, 0.7536, 3.58, 0.167, 409, 389, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
984, d4jwuB_, 0.7535, 3.20, 0.176, 397, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
985, d1geiA_, 0.7535, 3.24, 0.144, 409, 382, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
986, d5y5lA_, 0.7534, 3.33, 0.188, 411, 383, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
987, p5u6uA_, 0.7534, 3.33, 0.188, 411, 383, THE CRYSTAL STRUCTURE OF 4-ETHYLTHIOBENZOATE-BOUND CYP199A4 
988, d5y5kA_, 0.7533, 3.70, 0.171, 427, 398, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
989, d5y5jA_, 0.7533, 3.23, 0.171, 399, 380, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
990, d5y5iA_, 0.7533, 3.42, 0.125, 397, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
991, d5y5gA_, 0.7532, 2.24, 0.237, 362, 358, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
992, d2d0eA1, 0.7532, 3.26, 0.146, 394, 378, SUBSTRATE ASSITED IN OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
993, d1cmjA_, 0.7532, 3.26, 0.146, 394, 378, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
994, d4dnzC_, 0.7531, 3.43, 0.158, 406, 385, THE CRYSTAL STRUCTURES OF CYP199A4
995, d4dnzB_, 0.7531, 3.47, 0.150, 405, 386, THE CRYSTAL STRUCTURES OF CYP199A4
996, d5foiB_, 0.7530, 3.46, 0.161, 437, 386, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
997, d4jx1E_, 0.7530, 3.46, 0.161, 437, 386, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
998, d4egoC_, 0.7530, 3.36, 0.173, 405, 382, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
999, d4do1A_, 0.7530, 3.35, 0.127, 399, 379, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1000, d3w9cA_, 0.7530, 3.18, 0.146, 392, 376, CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
1001, d3p3zA1, 0.7530, 3.40, 0.161, 406, 385, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH FROM STREPTOMYCES THIOLUTEUS IN COMPLEX WITH ANCYMIDOL
1002, d1gejA_, 0.7530, 3.49, 0.153, 405, 386, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1003, d1f25A_, 0.7530, 3.40, 0.173, 403, 382, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ASN MUTANTS OF CYTOCHROME P450NOR
1004, d5y5lB_, 0.7529, 3.46, 0.156, 405, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
1005, d5y5jB_, 0.7529, 3.34, 0.126, 399, 382, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
1006, d5y5hA_, 0.7529, 3.34, 0.126, 399, 382, SF-ROX STRUCTURE OF CYTOCHROME P450NOR (NO-BOUND STATE) DETERMINED AT SACLA
1007, p5nwsA_, 0.7529, 3.41, 0.175, 403, 382, CRYSTAL STRUCTURE OF SAACMM INVOLVED IN ACTINOMYCIN BIOSYNTHESIS
1008, d3p6tA_, 0.7529, 3.50, 0.155, 406, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
1009, d5y5kB_, 0.7528, 3.46, 0.151, 406, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1010, d5y5iB_, 0.7528, 3.38, 0.173, 405, 382, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1011, d4egoB_, 0.7528, 3.38, 0.173, 405, 382, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1012, d1jfcA_, 0.7528, 3.08, 0.149, 389, 375, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERROUS CO STATE AT ATOMIC RESOLUTION
1013, d1jfbA_, 0.7528, 3.08, 0.149, 389, 375, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERRIC RESTING STATE AT ATOMIC RESOLUTION
1014, d1f24A_, 0.7528, 3.54, 0.158, 405, 386, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ALA MUTANTS OF CYTOCHROME P450NOR
1015, d5foiA1, 0.7527, 3.51, 0.153, 404, 385, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
1016, d4egoA_, 0.7527, 3.34, 0.171, 403, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1017, d3p6qA_, 0.7526, 3.27, 0.137, 394, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-ETG-BOC
1018, d3nv5A_, 0.7526, 3.29, 0.164, 402, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D2
1019, d1f26A_, 0.7526, 3.51, 0.158, 404, 385, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243VAL MUTANTS OF CYTOCHROME P450NOR
1020, d4egnC_, 0.7525, 3.33, 0.132, 399, 378, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1021, d4egnB_, 0.7525, 3.20, 0.196, 399, 377, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1022, d4egpA_, 0.7524, 3.20, 0.196, 399, 377, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
1023, d1cl6A_, 0.7524, 3.21, 0.180, 395, 377, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND ITS SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1024, p5uvbA_, 0.7523, 3.21, 0.180, 395, 377, THE CRYSTAL STRUCTURE OF 4-CYCLOPROPYLBENZOATE-BOUND CYP199A4
1025, d4egmC_, 0.7522, 3.19, 0.132, 411, 378, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1026, d4dnzA_, 0.7522, 3.15, 0.154, 396, 377, THE CRYSTAL STRUCTURES OF CYP199A4
1027, d1gedA_, 0.7522, 3.15, 0.154, 396, 377, A POSITIVE CHARGE ROUTE FOR THE ACCESS OF NADH TO HEME FORMED IN THE DISTAL HEME POCKET OF CYTOCHROME P450NOR
1028, p5kdyA_, 0.7521, 3.33, 0.127, 399, 378, THE CRYSTAL STRUCTURE OF THE D251N MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
1029, d4do1C_, 0.7521, 3.37, 0.173, 403, 382, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1030, d1eheA_, 0.7521, 3.37, 0.149, 402, 382, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1031, d4do1B_, 0.7520, 3.47, 0.146, 404, 384, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1032, d1ehgA_, 0.7520, 3.43, 0.162, 401, 382, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1033, p5kt1A_, 0.7519, 3.19, 0.138, 393, 378, THE CRYSTAL STRUCTURE OF 4-METHYLTHIOBENZOATE-BOUND CYP199A4
1034, d1cmnA_, 0.7519, 3.26, 0.135, 393, 379, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1035, d5y1iB_, 0.7518, 3.35, 0.157, 403, 382, THE CRYSTAL STRUCTURE OF GFSF
1036, d1re9A_, 0.7518, 3.34, 0.127, 399, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
1037, d4egnA_, 0.7517, 3.40, 0.127, 399, 379, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1038, d3p6oA_, 0.7517, 3.19, 0.138, 393, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-ETG-DANS
1039, d3abaA1, 0.7515, 3.40, 0.132, 399, 379, CRYSTAL STRUCTURE OF CYP105P1 IN COMPLEX WITH FILIPIN I
1040, d2zbzA1, 0.7515, 3.40, 0.127, 399, 379, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D3
1041, d1ehfA_, 0.7515, 3.40, 0.132, 399, 379, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1042, p5u6wA_, 0.7512, 3.44, 0.126, 400, 380, THE CRYSTAL STRUCTURE OF 4-METHYLAMINOBENZOATE-BOUND CYP199A4 
1043, d3ofuC_, 0.7512, 3.44, 0.126, 400, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1044, d3cv9A1, 0.7510, 3.25, 0.148, 401, 379, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R73A/R84A MUTANT) IN COMPLEX WITH 1ALPHA25- DIHYDROXYVITAMIN D3
1045, d1gwiB_, 0.7510, 3.40, 0.127, 399, 379, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
1046, d3ofuA_, 0.7507, 3.41, 0.138, 393, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1047, d5y5fA_, 0.7506, 3.27, 0.137, 393, 379, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
1048, d5x7eA1, 0.7505, 3.22, 0.152, 388, 374, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D2
1049, d3oftA_, 0.7505, 3.47, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1050, d3p6mA_, 0.7504, 3.41, 0.141, 393, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
1051, d3ol5A_, 0.7503, 3.28, 0.135, 393, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED WITH A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-C8-DANS
1052, d1wiyA_, 0.7503, 3.45, 0.162, 401, 382, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1053, p5kdzA_, 0.7502, 3.35, 0.179, 406, 380, THE CRYSTAL STRUCTURE OF THE T252A MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
1054, d1uedA_, 0.7502, 3.34, 0.127, 399, 378, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
1055, d3wriB1, 0.7501, 3.40, 0.124, 399, 379, CRYSTAL STRUCTURE OF P450CAM
1056, d3wriA1, 0.7501, 3.40, 0.127, 399, 379, CRYSTAL STRUCTURE OF P450CAM
1057, d1lwlA_, 0.7501, 3.40, 0.127, 399, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
1058, d3p6pA_, 0.7500, 3.44, 0.126, 400, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C6-BIO
1059, d3oiaA_, 0.7499, 3.28, 0.167, 395, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8GLUETG-BIO
1060, d5h1zA_, 0.7498, 3.28, 0.167, 395, 378, CYP153D17 FROM SPHINGOMONAS SP. PAMC 26605
1061, d3cv8A1, 0.7497, 3.46, 0.148, 404, 384, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84F MUTANT)
1062, d3rwlA_, 0.7496, 3.40, 0.127, 399, 379, STRUCTURE OF P450PYR HYDROXYLASE
1063, d4egoD_, 0.7491, 3.40, 0.127, 399, 379, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1064, d3p6nA_, 0.7491, 3.32, 0.132, 393, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
1065, d3p6wA_, 0.7490, 3.40, 0.127, 399, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-ETG-BOC
1066, d3l62A_, 0.7490, 3.40, 0.127, 399, 379, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT LOW [K+]
1067, d5l1pA_, 0.7489, 3.40, 0.124, 399, 379, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE
1068, d3p3oA1, 0.7489, 3.16, 0.150, 388, 373, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERMII) FROM STREPTOMYCES THIOLUTEUS
1069, d2d09A1, 0.7489, 3.16, 0.150, 388, 373, A ROLE FOR ACTIVE SITE WATER MOLECULES AND HYDROXYL GROUPS OF SUBSTRATE FOR OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
1070, d1t93A1, 0.7489, 3.28, 0.137, 393, 379, EVIDENCE FOR MULTIPLE SUBSTRATE RECOGNITION AND MOLECULAR MECHANISM OF C-C REACTION BY CYTOCHROME P450 CYP158A2 FROM STREPTOMYCES COELICOLOR A3(2)
1071, d4egpB_, 0.7487, 3.49, 0.154, 401, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
1072, d4do1D_, 0.7487, 3.43, 0.147, 399, 382, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1073, d3p6vA_, 0.7487, 3.40, 0.124, 399, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3ET-ADAC1-ETG-BOC
1074, d1uedB_, 0.7487, 3.41, 0.138, 393, 383, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
1075, d4yzrA_, 0.7486, 3.29, 0.135, 393, 379, BACILLUS SUBTILIS 168 BACILLAENE POLYKETIDE SYNTHASE (PKS) CYTOCHROME P450 PKSS
1076, d4egnD_, 0.7486, 3.30, 0.135, 393, 379, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1077, d4l49A_, 0.7484, 3.41, 0.127, 399, 379, STRUCTURE OF L358A MUTANT OF P450CAM BOUND TO CAMPHOR
1078, d5l1qA_, 0.7483, 3.22, 0.140, 393, 378, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH DIHYDROPENTALENOLACTONE F
1079, d4egmD_, 0.7483, 3.44, 0.135, 393, 384, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1080, d4dnzD_, 0.7483, 3.29, 0.137, 393, 379, THE CRYSTAL STRUCTURES OF CYP199A4
1081, d3ofuB_, 0.7483, 3.41, 0.127, 399, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1082, d4l4dA_, 0.7482, 3.41, 0.133, 393, 383, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A
1083, d2zbyA1, 0.7482, 3.38, 0.139, 393, 382, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT)
1084, d4l4eA_, 0.7481, 3.42, 0.127, 399, 379, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G
1085, d2h7qA_, 0.7481, 3.29, 0.135, 393, 379, CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
1086, d3nc3B_, 0.7480, 3.41, 0.127, 399, 379, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1087, d5l1sA_, 0.7478, 3.41, 0.133, 393, 383, X-RAY STRUCTURE OF F232L MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1088, d4l4fA_, 0.7478, 3.42, 0.127, 399, 379, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G/D182N
1089, d5l1uA_, 0.7477, 3.49, 0.135, 394, 378, X-RAY STRUCTURE OF M81A MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1090, d5cp4A_, 0.7477, 3.49, 0.135, 394, 378, CRYOGENIC STRUCTURE OF P450CAM
1091, d5l1vA_, 0.7476, 3.64, 0.147, 404, 387, X-RAY STRUCTURE OF M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1092, d4l4aA_, 0.7475, 3.33, 0.134, 393, 380, STRUCTURE OF L358A/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1093, d3p6rA_, 0.7474, 3.50, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-ETG-BOC
1094, d5wk7A_, 0.7473, 3.33, 0.175, 393, 377, P450CAM MUTANT R186A
1095, d5l1rA_, 0.7473, 3.19, 0.143, 403, 377, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PNTM
1096, d5l1oA_, 0.7473, 3.19, 0.143, 403, 377, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1097, d4pwvA_, 0.7472, 3.43, 0.127, 399, 379, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
1098, d5wk9A_, 0.7471, 3.43, 0.136, 393, 383, R186AP450CAM WITH CN AND CAMPHOR
1099, d3ofuD_, 0.7471, 3.51, 0.128, 396, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1100, d2z36A1, 0.7471, 3.08, 0.141, 399, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
1101, d1phcA_, 0.7471, 3.30, 0.158, 400, 379, CRYSTAL STRUCTURE OF SUBSTRATE-FREE PSEUDOMONAS PUTIDA CYTOCHROME P450
1102, d4l4bA_, 0.7469, 3.53, 0.128, 396, 384, STRUCTURE OF L358A/K178G/D182N MUTANT OF P450CAM BOUND TO CAMPHOR
1103, d1pkfA_, 0.7469, 3.44, 0.127, 399, 379, CRYSTAL STRUCTURE OF EPOTHILONE D-BOUND CYTOCHROME P450EPOK
1104, d1dz9A_, 0.7469, 3.21, 0.143, 403, 377, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1105, d1dz8A_, 0.7469, 3.54, 0.128, 396, 384, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1106, d1t86A_, 0.7468, 3.54, 0.128, 396, 384, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
1107, d1gekA_, 0.7468, 3.46, 0.151, 404, 384, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1108, d5l1tA_, 0.7467, 3.50, 0.148, 405, 385, X-RAY STRUCTURE OF M77S MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1109, d3p6xA_, 0.7467, 2.46, 0.244, 358, 357, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C8-DANS
1110, d1phbA_, 0.7467, 3.45, 0.141, 393, 383, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
1111, d1o76A_, 0.7467, 3.26, 0.157, 391, 375, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1112, d6cppA_, 0.7466, 3.26, 0.157, 391, 375, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1113, d5it1B_, 0.7466, 3.50, 0.159, 401, 383, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
1114, d5it1C_, 0.7465, 3.50, 0.159, 401, 383, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
1115, d3cp4A_, 0.7465, 3.56, 0.145, 404, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1116, d1phaA_, 0.7465, 3.65, 0.150, 407, 387, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
1117, d5it1D_, 0.7464, 3.50, 0.148, 405, 385, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
1118, d5it1A_, 0.7464, 3.37, 0.127, 400, 379, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
1119, d3ejdD_, 0.7464, 3.37, 0.127, 400, 379, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1120, d2z36B1, 0.7464, 3.11, 0.141, 400, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
1121, d1phfA_, 0.7464, 3.41, 0.111, 404, 380, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1122, d4apyA_, 0.7462, 3.47, 0.141, 393, 383, ETHYLENE GLYCOL-BOUND FORM OF P450 CYP125A3 FROM MYCOBACTERIUM SMEGMATIS
1123, d4cppA_, 0.7461, 3.61, 0.150, 404, 386, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1124, d3ejbH_, 0.7461, 3.42, 0.157, 400, 381, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1125, d1akdA_, 0.7461, 3.40, 0.155, 400, 381, CYTOCHROME P450CAM FROM PSEUDOMONAS PUTIDA COMPLEXED WITH 1S-CAMPHOR
1126, d4ubsA_, 0.7460, 3.37, 0.194, 397, 377, THE CRYSTAL STRUCTURE OF CYTOCHROME P450 105D7 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH DICLOFENAC
1127, d3l63A_, 0.7460, 3.49, 0.178, 406, 381, CRYSTAL STRUCTURE OF CAMPHOR-BOUND P450CAM AT LOW [K+]
1128, d1t87B_, 0.7460, 3.49, 0.178, 406, 381, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
1129, d1iwkA_, 0.7460, 3.36, 0.147, 401, 381, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(112K) CYTOCHROME P450CAM
1130, d3e5lA1, 0.7459, 3.35, 0.147, 401, 381, CRYSTAL STRUCTURE OF CYP105P1 H72A MUTANT
1131, d2ferA_, 0.7459, 3.35, 0.147, 401, 381, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1132, d1t86B_, 0.7459, 3.40, 0.139, 393, 381, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
1133, d5l1wA_, 0.7458, 3.47, 0.138, 393, 383, X-RAY STRUCTURE OF 2-MERCAPTOETHANOL MODIFIED M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1134, d4kkyX_, 0.7458, 3.42, 0.158, 398, 380, CRYSTAL STRUCTURE OF N-(1-PYRENE)ACETAMIDE LABELED P450CAM IN SUBSTRATE BOUND FORM.
1135, d2z3tA_, 0.7458, 3.17, 0.150, 391, 373, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1136, d1dz6A_, 0.7458, 3.10, 0.167, 388, 372, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
1137, d6cp4A_, 0.7457, 3.10, 0.167, 388, 372, P450CAM D251N MUTANT
1138, d2z97A_, 0.7457, 3.48, 0.138, 393, 383, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 7- METHYL-7-DEPROPIONATED HEMIN
1139, d2z3tC_, 0.7457, 3.61, 0.142, 405, 386, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1140, d1pheA_, 0.7456, 3.38, 0.194, 397, 377, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1141, d1gemA_, 0.7456, 3.47, 0.144, 393, 383, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1142, d1cp4A_, 0.7456, 3.47, 0.141, 393, 383, FORMATION CRYSTAL STRUCTURE AND REARRANGEMENT OF A CYTOCHROME P450-CAM IRON-PHENYL COMPLEX
1143, d3ejeD_, 0.7455, 3.58, 0.125, 396, 384, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1144, d2bvjB_, 0.7455, 3.64, 0.145, 405, 386, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
1145, d1phdA_, 0.7455, 3.14, 0.141, 399, 375, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1146, d8cppA_, 0.7454, 3.65, 0.145, 405, 386, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1147, d3b99B_, 0.7454, 3.65, 0.145, 405, 386, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1148, d2whwA_, 0.7454, 3.08, 0.148, 385, 371, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1149, d2a1oB_, 0.7454, 3.38, 0.191, 397, 377, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
1150, d1uyuA_, 0.7454, 3.65, 0.145, 405, 386, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
1151, d1phgA_, 0.7454, 3.36, 0.188, 397, 377, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1152, d1dz8B_, 0.7454, 3.65, 0.145, 406, 386, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1153, d1o76B_, 0.7453, 3.38, 0.191, 397, 377, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1154, d1nooA_, 0.7453, 3.65, 0.145, 405, 386, CYTOCHROME P450-CAM COMPLEXED WITH 5-EXO-HYDROXYCAMPHOR
1155, d5dqnA_, 0.7452, 3.43, 0.158, 398, 380, POLYETHYLENE 600-BOUND FORM OF P450 CYP125A3 MUTANT FROM MYOBACTERIUM SMEGMATIS - W83Y
1156, d3cppA_, 0.7452, 3.75, 0.142, 405, 388, CRYSTAL STRUCTURE OF THE CARBON MONOXY-SUBSTRATE-CYTOCHROME P450-CAM TERNARY COMPLEX
1157, d3oftB_, 0.7451, 3.38, 0.194, 397, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1158, d2qbmA_, 0.7451, 3.39, 0.191, 397, 377, CRYSTAL STRUCTURE OF THE P450CAM G248T MUTANT IN THE CYANIDE BOUND STATE
1159, d2cppA_, 0.7451, 3.39, 0.191, 397, 377, HIGH-RESOLUTION CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM
1160, d1t88A_, 0.7451, 3.63, 0.169, 404, 384, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
1161, d1t87A_, 0.7451, 3.75, 0.142, 405, 388, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
1162, d1dz9B_, 0.7451, 3.52, 0.128, 394, 382, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1163, d1dz6B_, 0.7451, 3.53, 0.164, 398, 378, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
1164, d4cp4A_, 0.7450, 3.65, 0.145, 405, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1165, d1s1fA1, 0.7450, 3.69, 0.145, 405, 387, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1166, d1dz4A_, 0.7450, 3.41, 0.168, 403, 380, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
1167, d5cppA_, 0.7449, 3.61, 0.145, 404, 385, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P-450(CAM)
1168, d2h7sA_, 0.7449, 3.69, 0.142, 404, 386, L244A MUTANT OF CYTOCHROME P450CAM
1169, d2frzA_, 0.7449, 3.65, 0.145, 406, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
1170, d2a1mB_, 0.7449, 3.66, 0.145, 406, 386, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
1171, d1iwiA_, 0.7449, 3.40, 0.191, 397, 377, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM
1172, d7cppA_, 0.7448, 3.41, 0.158, 399, 380, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P450(CAM)
1173, d3wrmF_, 0.7448, 3.65, 0.145, 405, 386, CRYSTAL STRUCTURE OF P450CAM
1174, d3wrlA_, 0.7448, 3.62, 0.145, 404, 385, CRYSTAL STRUCTURE OF P450CAM
1175, d2cp4A_, 0.7448, 3.69, 0.145, 405, 387, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1176, d2a1mA_, 0.7448, 3.63, 0.175, 395, 378, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
1177, d1uyuB_, 0.7448, 3.63, 0.175, 395, 378, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
1178, d4c9pA_, 0.7447, 3.66, 0.145, 405, 386, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
1179, d2feuB_, 0.7447, 3.65, 0.145, 405, 386, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1180, d1j51A_, 0.7447, 3.63, 0.175, 395, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1181, d1iwjA_, 0.7447, 3.63, 0.175, 395, 378, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(109K) CYTOCHROME P450CAM
1182, d4l4gA_, 0.7446, 3.63, 0.175, 395, 378, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358P/K178G
1183, d4c9nA_, 0.7446, 3.10, 0.168, 385, 370, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
1184, d3wrhA_, 0.7446, 3.53, 0.161, 399, 378, CRYSTAL STRUCTURE OF P450CAM
1185, d4ek1B_, 0.7445, 3.53, 0.161, 399, 378, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
1186, d3wrjE_, 0.7445, 3.66, 0.145, 405, 386, CRYSTAL STRUCTURE OF P450CAM
1187, d3ejbD_, 0.7445, 3.55, 0.167, 414, 383, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1188, d2a1oA_, 0.7445, 3.70, 0.145, 405, 387, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
1189, d4ek1A_, 0.7444, 3.17, 0.169, 387, 372, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
1190, d3wrmA_, 0.7444, 3.17, 0.169, 387, 372, CRYSTAL STRUCTURE OF P450CAM
1191, d1dz4B_, 0.7444, 3.66, 0.142, 405, 386, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
1192, d4c9oA_, 0.7443, 3.29, 0.168, 393, 376, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
1193, d2qblA_, 0.7443, 3.67, 0.145, 405, 386, CRYSTAL STRUCTURE OF FERRIC G248T CYTOCHROME P450CAM
1194, d2m56A_, 0.7443, 3.69, 0.145, 405, 386, THE STRUCTURE OF THE COMPLEX OF CYTOCHROME P450CAM AND ITS ELECTRON DONOR PUTIDAREDOXIN DETERMINED BY PARAMAGNETIC NMR SPECTROSCOPY
1195, d2gqxA_, 0.7443, 3.71, 0.145, 405, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
1196, d2a1nB_, 0.7443, 3.45, 0.178, 393, 376, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
1197, d1t88B_, 0.7443, 3.72, 0.142, 405, 387, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
1198, d1t85A_, 0.7443, 3.65, 0.142, 406, 386, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM MUTANT (L358P/C334A)
1199, d1mpwA_, 0.7443, 3.40, 0.186, 396, 377, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
1200, d1c8jA_, 0.7443, 3.60, 0.142, 411, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
1201, d3wrjA_, 0.7442, 3.60, 0.142, 411, 386, CRYSTAL STRUCTURE OF P450CAM
1202, d3wrhE_, 0.7442, 3.20, 0.172, 385, 372, CRYSTAL STRUCTURE OF P450CAM
1203, d3fwgA_, 0.7442, 3.69, 0.142, 404, 386, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
1204, d1j51C_, 0.7442, 3.69, 0.145, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1205, d1j51B_, 0.7442, 3.64, 0.148, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1206, d4umzA_, 0.7441, 3.16, 0.178, 383, 371, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
1207, d4c9lB_, 0.7441, 3.69, 0.145, 405, 386, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
1208, d4c9lA_, 0.7441, 3.67, 0.145, 405, 386, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
1209, d4c9kB_, 0.7441, 3.70, 0.145, 405, 387, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
1210, d2gr6B_, 0.7441, 3.13, 0.168, 385, 370, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
1211, d3wrlE_, 0.7440, 3.62, 0.174, 391, 379, CRYSTAL STRUCTURE OF P450CAM
1212, d2gr6A_, 0.7440, 3.67, 0.145, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
1213, d2a1nA_, 0.7440, 3.71, 0.145, 405, 387, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
1214, d1mpwB_, 0.7440, 3.53, 0.164, 415, 385, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
1215, d4c9mB_, 0.7439, 3.56, 0.168, 396, 382, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
1216, d4c9mA_, 0.7439, 3.71, 0.142, 405, 386, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
1217, d4c9kA_, 0.7439, 3.73, 0.142, 404, 387, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
1218, d3lxhA_, 0.7439, 3.68, 0.145, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
1219, d2h7sC_, 0.7439, 3.73, 0.142, 405, 387, L244A MUTANT OF CYTOCHROME P450CAM
1220, d1j51D_, 0.7439, 3.70, 0.145, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1221, d4l4cA_, 0.7438, 3.69, 0.145, 405, 386, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1222, d4c9pB_, 0.7438, 3.53, 0.160, 410, 382, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
1223, d1p7rA1, 0.7438, 3.71, 0.145, 405, 387, CRYSTAL STRUCTURE OF REDUCED CO-EXPOSED COMPLEX OF CYTOCHROME P450CAM WITH (S)-(-)-NICOTINE
1224, d4c9oB_, 0.7437, 3.53, 0.129, 393, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
1225, d1p2yA1, 0.7437, 3.70, 0.145, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM IN COMPLEX WITH (S)- (-)-NICOTINE
1226, d4wq0A_, 0.7436, 3.72, 0.145, 405, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH OLIGOMYCIN A
1227, d2wi9A_, 0.7436, 3.67, 0.142, 407, 386, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1228, d2zbxA1, 0.7435, 3.73, 0.145, 407, 387, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (WILD TYPE) WITH IMIDAZOLE BOUND
1229, d1gebA_, 0.7435, 3.74, 0.142, 405, 387, X-RAY CRYSTAL STRUCTURE AND CATALYTIC PROPERTIES OF THR252ILE MUTANT OF CYTOCHROME P450CAM
1230, d5cjeA_, 0.7434, 3.70, 0.142, 405, 386, STRUCTURE OF CYP107L2
1231, d4c9nB_, 0.7434, 3.69, 0.145, 405, 386, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
1232, d4bf4M_, 0.7434, 3.26, 0.155, 395, 375, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1233, d4bf4D_, 0.7434, 3.71, 0.142, 404, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1234, d2zaxA_, 0.7434, 3.69, 0.145, 405, 386, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
1235, d2gqxB_, 0.7434, 3.73, 0.145, 405, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
1236, d1yrdA_, 0.7434, 3.71, 0.145, 405, 386, X-RAY CRYSTAL STRUCTURE OF PERDEUTERATED CYTOCHROME P450CAM
1237, d2zwuA_, 0.7433, 3.67, 0.148, 405, 386, CRYSTAL STRUCTURE OF CAMPHOR SOAKED FERRIC CYTOCHROME P450CAM
1238, d2zuiA_, 0.7433, 3.72, 0.145, 405, 387, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297N)
1239, d1q5eA_, 0.7433, 3.71, 0.145, 405, 387, SUBSTRATE-FREE CYTOCHROME P450EPOK
1240, d2zuhA_, 0.7432, 3.67, 0.148, 405, 386, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297A)
1241, d2qboA_, 0.7432, 3.73, 0.145, 405, 387, CRYSTAL STRUCTURE OF THE P450CAM G248V MUTANT IN THE CYANIDE BOUND STATE
1242, d2feuA_, 0.7432, 3.72, 0.142, 405, 387, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1243, d4bf4N_, 0.7431, 3.67, 0.148, 405, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1244, d3fwgB_, 0.7431, 3.66, 0.145, 405, 386, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
1245, d2x5lA_, 0.7431, 3.61, 0.148, 408, 386, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 ALTERNATIVE CRYSTAL FORM
1246, d5y1iA_, 0.7430, 3.71, 0.145, 405, 386, THE CRYSTAL STRUCTURE OF GFSF
1247, d3lxiB_, 0.7430, 3.66, 0.148, 405, 386, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
1248, d3lxiA_, 0.7430, 3.72, 0.147, 405, 387, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
1249, d4bf4J_, 0.7429, 3.78, 0.144, 405, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1250, d2zwtA_, 0.7429, 3.61, 0.150, 408, 386, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
1251, d2qbnA_, 0.7429, 3.74, 0.145, 405, 387, CRYSTAL STRUCTURE OF FERRIC G248V CYTOCHROME P450CAM
1252, d3ejdB_, 0.7428, 3.73, 0.145, 404, 387, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1253, d2zawA_, 0.7428, 3.67, 0.148, 405, 386, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 6- METHYL-6-DEPROPIONATED HEMIN
1254, d1yrcA_, 0.7428, 3.18, 0.167, 386, 371, X-RAY CRYSTAL STRUCTURE OF HYDROGENATED CYTOCHROME P450CAM
1255, d2zujA_, 0.7427, 3.71, 0.145, 405, 386, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT(D297L)
1256, d2fe6A_, 0.7427, 3.68, 0.145, 403, 386, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1257, d4bf4O_, 0.7426, 3.61, 0.143, 405, 385, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1258, d3fwiA_, 0.7426, 3.67, 0.140, 405, 386, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND TETRAGONAL CRYSTAL FORM
1259, d1q5dA_, 0.7426, 3.62, 0.148, 408, 386, EPOTHILONE B-BOUND CYTOCHROME P450EPOK
1260, d5gweB_, 0.7425, 3.71, 0.145, 405, 386, CYTOCHROME P450 CREJ
1261, d3oftC_, 0.7425, 3.69, 0.140, 404, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1262, d3iw0A_, 0.7422, 3.74, 0.145, 405, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 C2221 CRYSTAL FORM
1263, d3nc5A_, 0.7421, 3.69, 0.148, 405, 386, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1264, d1c8jB_, 0.7421, 3.58, 0.143, 405, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
1265, d4bf4B_, 0.7420, 3.75, 0.142, 406, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1266, d4g3rA_, 0.7419, 3.61, 0.143, 405, 385, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
1267, d3ejeH_, 0.7418, 3.71, 0.145, 405, 386, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1268, d2frzB_, 0.7417, 3.61, 0.143, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
1269, d4g3rB_, 0.7416, 3.68, 0.142, 405, 386, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
1270, d4umzB_, 0.7415, 3.68, 0.145, 404, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
1271, d4bf4L_, 0.7414, 3.74, 0.145, 405, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1272, d3fwjA_, 0.7413, 3.65, 0.148, 405, 385, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND ORTHOROMBIC CRYSTAL FORM
1273, d2h7rA_, 0.7413, 3.64, 0.167, 396, 383, L244A MUTANT OF CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
1274, d4l4cB_, 0.7412, 3.67, 0.145, 407, 387, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1275, d4bf4E_, 0.7411, 3.69, 0.142, 408, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1276, d3lxhB_, 0.7411, 3.69, 0.144, 407, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
1277, d4b7dB_, 0.7410, 3.64, 0.148, 405, 385, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
1278, d3ejdF_, 0.7410, 3.61, 0.148, 405, 385, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1279, d4bf4H_, 0.7409, 3.74, 0.145, 405, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1280, d3tzoB1, 0.7409, 3.75, 0.147, 407, 387, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1281, d3ofuE_, 0.7409, 3.65, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1282, d3ejdH_, 0.7409, 3.72, 0.150, 407, 387, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1283, d2xc3A_, 0.7408, 3.62, 0.148, 408, 386, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP125 BOUND TO THE REVERSE TYPE I INHIBITOR
1284, d2xfhA_, 0.7407, 3.62, 0.148, 408, 386, STRUCTURE OF CYTOCHROME P450 ERYK COCRYSTALLIZED WITH INHIBITOR CLOTRIMAZOLE.
1285, d2z3tD_, 0.7406, 3.62, 0.150, 408, 386, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1286, d2wi9B_, 0.7406, 3.62, 0.150, 408, 386, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1287, d2vzmA_, 0.7406, 3.71, 0.145, 405, 386, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
1288, d1gjmA_, 0.7405, 3.65, 0.148, 405, 385, COVALENT ATTACHMENT OF AN ELECTROACTIVE SULPHYDRYL REAGENT IN THE ACTIVE SITE OF CYTOCHROME P450CAM
1289, d3zpiB_, 0.7404, 3.76, 0.145, 405, 387, PIKC D50N MUTANT IN P21 SPACE GROUP
1290, d5de9A1, 0.7402, 3.62, 0.145, 407, 386, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1291, d4bf4P_, 0.7402, 3.67, 0.148, 405, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1292, d4bf4F_, 0.7402, 3.70, 0.144, 407, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1293, d3ofuF_, 0.7402, 3.67, 0.148, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1294, d2whwB_, 0.7402, 3.52, 0.175, 397, 378, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1295, d5ibeA_, 0.7401, 3.52, 0.175, 397, 378, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25A
1296, d5de9B1, 0.7400, 3.59, 0.168, 396, 382, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1297, d4ktkA_, 0.7400, 3.22, 0.144, 395, 374, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-4-(4-HYDROXYPHENYL)-1H-PYRAZOL-5-YL)BENZENE-13-DIOL
1298, d4g1xA_, 0.7400, 3.67, 0.145, 405, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(1H-124-TRIAZOL-1-YL)QUINOLIN-6-AMINE
1299, d4bf4A_, 0.7400, 3.47, 0.162, 390, 376, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1300, d3g5fA_, 0.7399, 3.71, 0.144, 407, 388, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
1301, p5o4kA_, 0.7397, 3.64, 0.165, 397, 382, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6B.
1302, d3zk5A_, 0.7397, 3.68, 0.162, 397, 383, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
1303, d3l61A_, 0.7397, 3.62, 0.143, 405, 385, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT 200 MM [K+]
1304, d3fwfB_, 0.7397, 3.66, 0.148, 405, 385, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
1305, p5op9A_, 0.7396, 3.58, 0.143, 405, 384, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7E
1306, d5li8A_, 0.7396, 3.62, 0.143, 405, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH KETOCONAZOLE
1307, d5ibjA_, 0.7396, 3.62, 0.143, 405, 385, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 6
1308, d4g47A_, 0.7396, 3.49, 0.168, 404, 380, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-(1H-124- TRIAZOL-1-YL)PHENOL
1309, d4bf4G_, 0.7396, 3.49, 0.168, 404, 380, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1310, d3cxvA_, 0.7396, 3.62, 0.148, 405, 385, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 A233G MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
1311, d5ibdA_, 0.7395, 3.76, 0.147, 405, 387, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 24A
1312, d5cweA_, 0.7395, 3.74, 0.145, 404, 386, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
1313, d4ktjA_, 0.7395, 3.67, 0.167, 397, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-1H-PYRAZOL-4-YL)PHENOL
1314, d4g44A_, 0.7395, 3.63, 0.138, 405, 385, STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND MB286 3-((1H- 124-TRIAZOL-1-YL)METHYL)ANILINE
1315, d4g2gA_, 0.7395, 3.58, 0.147, 414, 381, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(1H-123-TRIAZOLE-15-DIYL)DIPHENOL
1316, d3cxxA_, 0.7395, 3.58, 0.147, 414, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 F338H FROM M. TUBERCULOSIS
1317, d2xn8A_, 0.7395, 3.39, 0.137, 388, 372, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125
1318, d3tzoA1, 0.7394, 3.63, 0.150, 407, 386, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1319, d3cxzA_, 0.7394, 3.63, 0.148, 408, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 R386L MUTANT FROM M. TUBERCULOSIS
1320, d4g48A_, 0.7393, 3.66, 0.165, 397, 382, STRUCTURE OF CYP121 IN COMPLEX WITH 4-(4-PHENOXY-1H-PYRAZOL-3-YL) BENZENE-13-DIOL
1321, d5ibhA_, 0.7392, 3.63, 0.143, 405, 385, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26H
1322, d5edtA_, 0.7392, 3.76, 0.145, 405, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH LIG9
1323, d4g46A_, 0.7392, 3.03, 0.177, 382, 367, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-OXO-4567- TETRAHYDROBENZOFURAN-3-CARBOXYLATE
1324, d3zk5B_, 0.7392, 3.58, 0.143, 405, 384, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
1325, d1n40A_, 0.7392, 3.59, 0.143, 405, 384, ATOMIC STRUCTURE OF CYP121 A MYCOBACTERIAL P450
1326, d4ktlA_, 0.7391, 3.63, 0.143, 405, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-((4-HYDROXYPHENYL)AMINO)-1H-PYRAZOLE-45-DIYL)DIPHENOL
1327, d3cxyA_, 0.7391, 3.73, 0.145, 405, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 P346L MUTANT FROM M. TUBERCULOSIS
1328, d3ejbB_, 0.7390, 3.63, 0.165, 397, 382, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1329, d4b7sA_, 0.7389, 3.74, 0.140, 405, 386, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
1330, d3zpiA_, 0.7389, 3.42, 0.175, 401, 378, PIKC D50N MUTANT IN P21 SPACE GROUP
1331, d2vzmB_, 0.7389, 3.30, 0.169, 396, 373, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
1332, d4bf4I_, 0.7388, 3.49, 0.127, 390, 378, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1333, d3cy1A_, 0.7388, 3.54, 0.153, 407, 380, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 S279A MUTANT FROM M. TUBERCULOSIS
1334, d2y5nB1, 0.7388, 3.06, 0.150, 384, 367, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
1335, d4g45A_, 0.7387, 3.65, 0.148, 405, 385, STRUCTURE OF CYTOCHROME CYP121 IN COMPLEX WITH 2-METHYLQUINOLIN-6- AMINE
1336, p5wp2A_, 0.7386, 3.63, 0.165, 397, 382, 1.44 ANGSTROM CRYSTAL STRUCTURE OF CYP121 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH SUBSTRATE AND CN 
1337, d4bf4K_, 0.7386, 3.65, 0.143, 407, 385, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1338, d4ipsA_, 0.7385, 3.13, 0.171, 383, 368, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1339, d4ictA_, 0.7385, 3.71, 0.145, 405, 386, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1340, d3fwfA_, 0.7385, 3.72, 0.148, 405, 386, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
1341, d3ejeF_, 0.7385, 3.65, 0.165, 395, 382, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1342, p5o4lA_, 0.7384, 3.59, 0.163, 397, 381, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6A.
1343, d5ik1A_, 0.7384, 3.65, 0.143, 405, 385, OPEN STATE OF P450CAM AFTER SOAKING IN CAMPHOR
1344, d5ibiA_, 0.7384, 3.77, 0.145, 405, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26A
1345, d5ex6A_, 0.7384, 3.66, 0.145, 405, 385, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1346, d4iq7A_, 0.7384, 3.66, 0.165, 397, 382, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1347, d4bf4C_, 0.7384, 3.63, 0.148, 405, 385, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1348, d3cy0A_, 0.7384, 3.58, 0.166, 393, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 S237A MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
1349, d3a4hA_, 0.7384, 3.02, 0.172, 381, 366, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (ORTHORHOMBIC CRYSTAL FORM)
1350, d3iw2A_, 0.7383, 3.64, 0.165, 396, 381, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ECONAZOLE
1351, d4ipwA_, 0.7382, 3.44, 0.141, 400, 376, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1352, d3wecA_, 0.7382, 3.51, 0.130, 390, 378, STRUCTURE OF P450 RAUA (CYP1050A1) COMPLEXED WITH A BIOSYNTHETIC INTERMEDIATE OF AURACHIN RE
1353, d5l91A1, 0.7381, 3.08, 0.172, 382, 367, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
1354, d5cweB_, 0.7380, 3.54, 0.150, 409, 379, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
1355, d4iq9A_, 0.7379, 3.53, 0.164, 394, 378, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1356, d5ibfA_, 0.7378, 3.12, 0.171, 379, 368, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 19A
1357, d3iw1A_, 0.7378, 3.58, 0.166, 394, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ANDROSTENEDIONE
1358, d2c6hB_, 0.7378, 3.61, 0.168, 395, 381, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1359, d3ivyA_, 0.7377, 3.75, 0.143, 405, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 P212121 CRYSTAL FORM
1360, d3g5hA_, 0.7377, 3.67, 0.168, 396, 382, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
1361, d3mgxB_, 0.7376, 3.45, 0.141, 400, 376, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
1362, d2c6hA_, 0.7376, 3.61, 0.166, 396, 380, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1363, d2jjpA_, 0.7375, 3.57, 0.163, 396, 380, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH INHIBITOR KETOCONAZOLE (KC)
1364, d5ex6C_, 0.7374, 3.57, 0.129, 390, 379, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1365, d4ktfA_, 0.7374, 3.55, 0.166, 393, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-AMINO-1H-PYRAZOLE-45-DIYL)DIPHENOL
1366, d1se6B1, 0.7374, 3.59, 0.156, 394, 378, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1367, p5opaA_, 0.7373, 3.49, 0.143, 400, 377, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7B
1368, d2y5zC_, 0.7372, 3.52, 0.154, 394, 377, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1369, d2c7xA_, 0.7372, 3.57, 0.151, 394, 378, CRYSTAL STRUCTURE OF NARBOMYCIN-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1370, d4jwsB_, 0.7368, 3.62, 0.165, 396, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
1371, d4aw3B_, 0.7367, 3.58, 0.153, 394, 378, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
1372, d2ycaA_, 0.7367, 3.58, 0.153, 394, 378, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN P21212 SPACE GROUP
1373, d2y5zB_, 0.7367, 3.71, 0.162, 397, 383, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1374, d2lqdA_, 0.7366, 3.71, 0.162, 397, 383, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1375, d3tywD1, 0.7365, 3.44, 0.154, 396, 377, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1376, d3tywC1, 0.7365, 3.82, 0.137, 405, 387, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1377, d4b7dA_, 0.7364, 3.54, 0.151, 394, 377, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
1378, d3r9bC_, 0.7364, 3.37, 0.152, 390, 374, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1379, d3ejbF_, 0.7364, 3.49, 0.157, 393, 376, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1380, d2ij5C_, 0.7364, 3.51, 0.151, 394, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1381, d4b7sB_, 0.7363, 3.63, 0.165, 396, 381, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
1382, d3r9bB_, 0.7363, 3.58, 0.151, 394, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1383, d3r9bA_, 0.7363, 3.48, 0.154, 394, 376, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1384, d4ggvA_, 0.7361, 3.56, 0.159, 393, 378, CRYSTAL STRUCTURE OF HMTT INVOLVED IN HIMASTATIN BIOSYNTHESIS
1385, d2y5nA_, 0.7361, 3.58, 0.151, 394, 378, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
1386, d2ij7E_, 0.7361, 3.51, 0.151, 394, 377, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1387, d2ij5B_, 0.7361, 3.58, 0.153, 394, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1388, d2jjoA_, 0.7360, 3.59, 0.151, 394, 378, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH ITS NATURAL SUBSTRATE ERD
1389, d4xe3B_, 0.7358, 3.60, 0.153, 409, 380, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
1390, d3e5kA1, 0.7358, 3.47, 0.138, 400, 376, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE 4-PHENYLIMIDAZOLE COMPLEX
1391, d3e5jA1, 0.7358, 3.59, 0.151, 394, 378, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE LIGAND-FREE FORM
1392, d2ij7B_, 0.7356, 3.49, 0.152, 394, 376, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1393, d1lgfA_, 0.7356, 3.52, 0.154, 393, 377, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1394, d2ca0A_, 0.7355, 3.56, 0.151, 394, 378, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
1395, d4tx3A_, 0.7353, 3.52, 0.154, 394, 377, COMPLEX OF THE X-DOMAIN AND OXYB FROM TEICOPLANIN BIOSYNTHESIS
1396, d2ygxD_, 0.7353, 3.62, 0.166, 394, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1397, d4wpzA_, 0.7352, 3.58, 0.151, 394, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS
1398, d2jjnA_, 0.7352, 3.58, 0.151, 394, 378, STRUCTURE OF CLOSED CYTOCHROME P450 ERYK
1399, d3zsnC_, 0.7351, 3.53, 0.154, 394, 377, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1400, d3zsnB_, 0.7351, 3.47, 0.149, 393, 376, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1401, d3mgxA_, 0.7351, 3.04, 0.173, 380, 365, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
1402, d2ygxB_, 0.7351, 3.62, 0.163, 397, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1403, d1n4gA_, 0.7351, 3.72, 0.168, 396, 382, STRUCTURE OF CYP121 A MYCOBACTERIAL P450 IN COMPLEX WITH IODOPYRAZOLE
1404, d3zsnA_, 0.7350, 3.60, 0.166, 394, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1405, d4yt3B_, 0.7349, 3.73, 0.168, 396, 382, CYP106A2
1406, p5mnsA_, 0.7348, 3.59, 0.151, 394, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1407, d5hdiA_, 0.7348, 3.50, 0.174, 397, 374, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
1408, d5gnmC_, 0.7348, 3.50, 0.174, 397, 374, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1409, d3ejeB_, 0.7348, 3.54, 0.154, 394, 377, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1410, d2y5zA_, 0.7347, 3.54, 0.154, 394, 377, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1411, d5vwsA_, 0.7346, 3.64, 0.163, 397, 381, LIGAND FREE STRUCTURE OF CYTOCHROME P450 TBTJ1
1412, d4jwsA_, 0.7346, 3.54, 0.154, 394, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
1413, d2z3tB_, 0.7346, 3.53, 0.154, 394, 377, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1414, d4z5pA_, 0.7345, 3.71, 0.140, 404, 385, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
1415, d3tywA1, 0.7345, 3.06, 0.170, 380, 365, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1416, d2y46C_, 0.7345, 3.58, 0.154, 393, 377, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1417, p5mnsB_, 0.7344, 3.43, 0.160, 394, 375, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1418, d5gnmD_, 0.7344, 3.49, 0.152, 393, 376, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1419, d2y46B_, 0.7344, 3.15, 0.136, 386, 367, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1420, d3tywB1, 0.7343, 3.54, 0.151, 394, 377, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1421, d2ij5A_, 0.7343, 3.62, 0.163, 396, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1422, d2y46A_, 0.7342, 3.54, 0.151, 394, 377, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1423, d2dkkA1, 0.7342, 3.64, 0.159, 400, 377, STRUCTURE/FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1424, d5ibgA_, 0.7341, 3.35, 0.147, 398, 373, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25B
1425, d2ygxA_, 0.7341, 3.50, 0.154, 394, 376, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1426, d4xe3A_, 0.7340, 3.57, 0.138, 401, 378, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
1427, d3nc3A_, 0.7340, 3.57, 0.138, 401, 378, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1428, d2vrvA_, 0.7340, 3.57, 0.205, 388, 371,  
1429, d2ygxC_, 0.7339, 3.57, 0.205, 388, 371, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1430, d2ij7D_, 0.7339, 3.54, 0.159, 393, 377, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1431, d5l90A1, 0.7338, 3.53, 0.154, 394, 377, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
1432, d5ex6B_, 0.7337, 3.48, 0.149, 393, 376, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1433, d4z5pB_, 0.7337, 3.37, 0.147, 398, 373, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
1434, d5ofqD_, 0.7336, 3.63, 0.166, 394, 380, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1435, d3a51D_, 0.7336, 3.43, 0.147, 399, 374, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1436, d2ij5D_, 0.7336, 3.53, 0.151, 394, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1437, d2xbkA_, 0.7335, 3.33, 0.159, 391, 371, X-RAY STRUCTURE OF THE SUBSTRATE-BOUND CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
1438, d2bvjA_, 0.7334, 3.33, 0.159, 391, 371, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
1439, p5mnvB_, 0.7332, 3.58, 0.166, 393, 379, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1440, d5l90B1, 0.7332, 3.60, 0.166, 397, 379, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
1441, d2nz5A1, 0.7332, 3.60, 0.166, 397, 379, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1442, d2y98A_, 0.7331, 3.17, 0.136, 388, 367, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN P21212 SPACE GROUP
1443, d5l91B1, 0.7330, 3.52, 0.152, 392, 376, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
1444, d2ij7F_, 0.7329, 3.54, 0.147, 400, 375, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1445, d2ij7A_, 0.7329, 3.51, 0.154, 393, 376, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1446, d2ij7C_, 0.7326, 3.52, 0.176, 394, 375, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1447, d2wioA_, 0.7325, 3.79, 0.167, 396, 383, STRUCTURE OF THE  HISTIDINE TAGGED OPEN CYTOCHROME P450 ERYK FROM S. ERYTHRAEA
1448, d2cd8B_, 0.7323, 3.54, 0.168, 395, 376, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1449, d2cd8A_, 0.7322, 3.38, 0.170, 393, 371, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1450, d4yt3A_, 0.7320, 3.38, 0.170, 393, 371, CYP106A2
1451, d5l92A_, 0.7319, 3.54, 0.176, 394, 375, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
1452, d5ofqA_, 0.7318, 3.69, 0.156, 405, 384, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1453, d3a51A_, 0.7318, 3.51, 0.142, 395, 372, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1454, d3r9cA_, 0.7316, 3.51, 0.142, 395, 372, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 WITH ECONAZOLE BOUND
1455, d2l8mA_, 0.7315, 3.60, 0.166, 393, 379, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1456, p5d40A_, 0.7312, 3.46, 0.177, 391, 373, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1457, d4aw3A_, 0.7312, 3.20, 0.167, 378, 366, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
1458, d3a50A_, 0.7312, 3.47, 0.152, 394, 376, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1459, d3a4zA_, 0.7312, 3.57, 0.164, 393, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1460, p5d3uA_, 0.7311, 3.46, 0.177, 391, 373, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1461, d4fxbA_, 0.7311, 3.46, 0.177, 391, 373, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
1462, d2ca0B_, 0.7311, 3.41, 0.156, 396, 371, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
1463, d5gnmB_, 0.7310, 3.41, 0.156, 396, 371, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1464, d3a4zE_, 0.7308, 3.57, 0.179, 394, 375, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1465, p5livD_, 0.7307, 3.53, 0.157, 391, 376, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1466, d3zkpA_, 0.7307, 3.42, 0.152, 390, 375, STRUCTURE OF A MUTANT OF P450 ERYK IN COMPLEX WITH ERYTHROMYCIN B.
1467, d3a51E_, 0.7307, 3.59, 0.162, 393, 376, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1468, d3vrmA_, 0.7306, 3.58, 0.170, 394, 376, STRUCTURE OF CYTOCHROME P450 VDH MUTANT T107A WITH BOUND VITAMIN D3
1469, d3a4zD_, 0.7306, 3.27, 0.172, 380, 367, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1470, d2uuqA_, 0.7306, 3.49, 0.177, 389, 373, CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM
1471, d3nc6A_, 0.7304, 3.46, 0.155, 391, 374, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
1472, d3nc5B_, 0.7303, 3.26, 0.141, 388, 368, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1473, d3a51B_, 0.7302, 3.26, 0.141, 388, 368, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1474, d2nzaA1, 0.7302, 3.57, 0.164, 393, 378, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1475, d5ofqC_, 0.7301, 3.06, 0.135, 373, 363, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1476, d3a50D_, 0.7301, 3.55, 0.176, 393, 375, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1477, d2nz5B1, 0.7301, 3.38, 0.178, 386, 371, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1478, p5mnvA_, 0.7298, 3.66, 0.164, 395, 379, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1479, d3a4zB_, 0.7297, 3.53, 0.171, 393, 374, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1480, d3a51C_, 0.7296, 3.53, 0.176, 393, 374, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1481, p5d40B_, 0.7295, 3.32, 0.159, 387, 370, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1482, d3wrkD1, 0.7295, 3.56, 0.176, 393, 375, CRYSTAL STRUCTURE OF P450CAM
1483, d3a50E_, 0.7295, 3.43, 0.153, 392, 373, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1484, d3a50B_, 0.7295, 3.53, 0.174, 393, 374, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1485, p5d3uB_, 0.7293, 3.35, 0.182, 388, 369, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1486, d5l94A_, 0.7292, 3.49, 0.170, 395, 377, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
1487, d3a4gA_, 0.7291, 3.37, 0.174, 397, 373, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (TRIGONAL CRYSTAL FORM)
1488, d2whfA_, 0.7291, 3.37, 0.174, 397, 373, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1489, d1lg9A_, 0.7291, 3.71, 0.159, 401, 377, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1490, p5mnvH_, 0.7290, 3.05, 0.168, 378, 363, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1491, d3a4zC_, 0.7289, 3.54, 0.176, 393, 374, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1492, d5gnmA_, 0.7288, 3.23, 0.161, 376, 366, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1493, d3a50C_, 0.7288, 3.23, 0.161, 376, 366, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1494, d2ij5E_, 0.7286, 3.42, 0.153, 392, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1495, d3abbA1, 0.7284, 3.07, 0.173, 376, 364, CRYSTAL STRUCTURE OF CYP105D6
1496, d5l92B_, 0.7283, 3.47, 0.175, 388, 371, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
1497, d5ikiA_, 0.7282, 3.47, 0.175, 388, 371, CYP106A2 WITH SUBSTRATE ABIETIC ACID
1498, p4oqsA_, 0.7281, 3.55, 0.142, 395, 372, CRYSTAL STRUCTURE OF CYP105AS1
1499, d5kyoB_, 0.7280, 3.55, 0.142, 395, 372, CRYSTAL STRUCTURE OF CYP101J2
1500, p5mnsF_, 0.7278, 3.55, 0.179, 393, 374, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1501, d5hiwA1, 0.7278, 3.50, 0.170, 395, 377, SORANGIUM CELLULOSUM SO CE56 CYTOCHROME P450 260B1
1502, d1lfkA_, 0.7276, 3.66, 0.162, 401, 376, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1503, d5gnlA_, 0.7275, 3.54, 0.176, 393, 374, CYTOCHROME P450 VDH (CYP107BR1) F106V MUTANT
1504, d3wrkA1, 0.7275, 3.56, 0.142, 395, 372, CRYSTAL STRUCTURE OF P450CAM
1505, d2wgyA_, 0.7273, 3.50, 0.157, 392, 375, CRYSTAL STRUCTURE OF THE G243A MUTANT OF CYP130 FROM M. TUBERCULOSIS
1506, d5lieB_, 0.7270, 3.55, 0.179, 393, 374, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
1507, d2ij5F_, 0.7269, 3.69, 0.135, 395, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1508, d5ofqB_, 0.7263, 3.39, 0.151, 390, 372, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1509, d5kyoA_, 0.7261, 3.54, 0.179, 393, 374, CRYSTAL STRUCTURE OF CYP101J2
1510, d3o1aA_, 0.7257, 3.62, 0.165, 394, 376, STRUCTURE OF OXYE (CYP165D3) A CYTOCHROME P450 INVOLVED IN TEICOPLANIN BIOSYNTHESIS
1511, d2wh8A_, 0.7255, 3.05, 0.152, 380, 363, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1512, d2nzaB1, 0.7254, 3.55, 0.160, 391, 375, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1513, p4l36A_, 0.7252, 3.55, 0.176, 393, 374, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1514, d5hdiB_, 0.7251, 3.49, 0.158, 391, 374, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
1515, d5kyoE_, 0.7250, 3.54, 0.206, 384, 369, CRYSTAL STRUCTURE OF CYP101J2
1516, d5uhuA_, 0.7247, 2.96, 0.139, 371, 361, SOLUTION CONFORMATION OF CYTOCHROME P450 MYCG WITH MYCINAMICIN IV BOUND
1517, d2wh8D_, 0.7246, 3.49, 0.170, 388, 371, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1518, d5hh3A_, 0.7241, 3.62, 0.177, 387, 373, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1519, d2wh8B_, 0.7240, 3.62, 0.177, 387, 373, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1520, d2wh8C_, 0.7229, 3.76, 0.169, 402, 378, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1521, d5kyoC_, 0.7227, 3.51, 0.158, 391, 374, CRYSTAL STRUCTURE OF CYP101J2
1522, d3oo3A_, 0.7207, 3.25, 0.150, 391, 367, CRYSTAL STRUCTURE OF THE ORF6* (CYP165D3) MONOOXYGENASE INVOLVED IN TEICOPLANIN BIOSYNTHESIS
1523, d4fxbB_, 0.7204, 3.25, 0.150, 391, 367, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
1524, d5hh3C1, 0.7192, 3.67, 0.164, 394, 379, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1525, d2uvnA1, 0.7189, 3.49, 0.173, 394, 376, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
1526, d5l94B_, 0.7179, 3.57, 0.206, 384, 369, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
1527, d5lieA_, 0.7172, 3.67, 0.138, 395, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
1528, d5li6A_, 0.7162, 3.60, 0.179, 393, 375, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
1529, d4rm4A_, 0.7160, 3.53, 0.209, 387, 369, THE CRYSTAL STRUCTURE OF THE VERSATILE CYTOCHROME P450 ENZYME CYP109B1 FROM BACILLUS SUBTILIS
1530, d5li6B_, 0.7156, 3.44, 0.155, 391, 373, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
1531, d1se6A1, 0.7150, 3.37, 0.156, 391, 372, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1532, d5kyoF_, 0.7130, 3.44, 0.155, 391, 373, CRYSTAL STRUCTURE OF CYP101J2
1533, d5kyoD_, 0.7096, 3.77, 0.162, 393, 377, CRYSTAL STRUCTURE OF CYP101J2
1534, d3b4xA_, 0.7084, 3.69, 0.166, 392, 379, CRYSTAL STRUCTURE ANALYSIS OF SULFOLOBUS TOKODAII STRAIN7 CYTOCHROM P450
1535, d2uvnB_, 0.7084, 3.68, 0.167, 391, 378, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
1536, d2x9pA_, 0.7052, 3.35, 0.179, 388, 368, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
1537, p5mnvG_, 0.7049, 3.48, 0.204, 386, 372, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1538, d1ue8A_, 0.7046, 3.77, 0.173, 386, 375, CRYSTAL STRUCTURE OF THERMOPHILIC CYTOCHROME P450 FROM SULFOLOBUS TOKODAII
1539, d4z5qA_, 0.7038, 3.79, 0.175, 402, 378, CRYSTAL STRUCTURE OF THE LNMZ CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.8 A RESOLUTION
1540, d5li7A_, 0.7034, 3.55, 0.187, 400, 374, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1541, d1f4tB_, 0.7034, 3.55, 0.187, 400, 374, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1542, d5li7B_, 0.7026, 3.75, 0.141, 405, 384, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1543, d1io9A_, 0.7023, 3.72, 0.145, 403, 380, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1544, d1io7A_, 0.7011, 3.56, 0.179, 393, 374, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1545, d1f4tA_, 0.7008, 3.80, 0.175, 402, 378, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1546, d1io8A_, 0.7006, 3.81, 0.175, 402, 378, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1547, d4wpdA_, 0.7003, 3.81, 0.175, 402, 378, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1548, d4wpdB_, 0.7002, 3.73, 0.145, 403, 380, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1549, d4e2pA_, 0.6989, 3.73, 0.145, 403, 380, CRYSTAL STRUCTURE OF A POST-TAILORING HYDROXYLASE (HMTN) INVOLVED IN THE HIMASTATIN BIOSYNTHESIS
1550, d4wqjA_, 0.6981, 3.37, 0.144, 390, 369, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COLLECTED AT 298K AND COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1551, d4tuvA_, 0.6975, 3.65, 0.159, 393, 378, X-RAY CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1552, d4tt5A_, 0.6971, 3.68, 0.160, 399, 375, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1553, d1f4uB_, 0.6950, 3.67, 0.171, 401, 375, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1554, d1f4uA_, 0.6950, 3.60, 0.160, 389, 375, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1555, d4tvfA_, 0.6902, 3.60, 0.160, 389, 375, OXYB FROM ACTINOPLANES TEICHOMYCETICUS
1556, d1io7B_, 0.6893, 3.60, 0.166, 390, 374, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1557, d1io8B_, 0.6887, 3.66, 0.168, 401, 375, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1558, d1io9B_, 0.6855, 3.43, 0.175, 402, 371, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1559, d2rfcD_, 0.6782, 3.73, 0.173, 401, 376, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1560, d2rfcA_, 0.6782, 3.48, 0.137, 394, 373, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1561, d2rfcC_, 0.6776, 2.94, 0.153, 374, 360, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1562, d2rfbA_, 0.6712, 3.00, 0.147, 373, 360, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1563, d2rfcB_, 0.6685, 3.58, 0.174, 402, 374, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1564, p6fshD1, 0.6676, 3.68, 0.141, 395, 376, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1565, p3g93A1, 0.6668, 3.74, 0.174, 386, 374, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1566, p5tftB1, 0.6659, 3.73, 0.176, 401, 376, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1567, p6fshA1, 0.6648, 3.71, 0.138, 395, 376, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1568, p6fshB1, 0.6642, 3.68, 0.162, 397, 376, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1569, p6fshC1, 0.6634, 3.68, 0.162, 397, 376, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1570, d2rfbC_, 0.6628, 3.59, 0.171, 402, 374, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1571, d2rfbB_, 0.6625, 3.73, 0.170, 401, 376, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1572, p3g93C1, 0.6495, 3.75, 0.145, 403, 380, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1573, p3g93D1, 0.6465, 3.43, 0.156, 390, 371, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1574, p3r1bC1, 0.6461, 3.69, 0.165, 401, 375, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1575, p3r1bD1, 0.6294, 3.60, 0.174, 402, 374, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1576, p3r1bB1, 0.6289, 3.78, 0.150, 403, 381, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1577, d5bv5D_, 0.6271, 3.50, 0.199, 385, 371, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1578, d5bv5A_, 0.6228, 3.62, 0.169, 395, 373, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1579, p3g93B1, 0.6222, 3.50, 0.137, 394, 373, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1580, d5bv5C_, 0.6101, 3.10, 0.136, 377, 361, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1581, p4l0eA2, 0.6041, 3.71, 0.164, 395, 377, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (HEME-COORDINATED EXPRESSION TAG)
1582, p5omuA1, 0.6026, 3.69, 0.171, 401, 375, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH SYRINGOL 
1583, p2vz7A1, 0.5975, 3.67, 0.166, 399, 374, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1584, p3be0A1, 0.5973, 3.75, 0.170, 401, 376, THE ROLE OF ASN 242 IN P450CIN
1585, p5u6tA1, 0.5961, 3.53, 0.153, 387, 372, THE CRYSTAL STRUCTURE OF 4-ETHOXYBENZOATE-BOUND CYP199A4 
1586, p2vz7B1, 0.5931, 3.21, 0.168, 379, 363, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1587, p6bldA1, 0.5882, 3.18, 0.212, 370, 359, MYCOBACTERIUM MARINUM CYTOCHROME P450 CYP268A2 IN COMPLEX WITH PSEUDOIONONE
1588, p5mnvD1, 0.5823, 3.39, 0.185, 383, 367, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1589, p5livB1, 0.5774, 3.64, 0.154, 384, 369, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1590, p3be0B1, 0.5770, 3.64, 0.154, 384, 369, THE ROLE OF ASN 242 IN P450CIN
1591, p4tpoA1, 0.5767, 3.56, 0.149, 393, 375, HIGH-RESOLUTION STRUCTURE OF TXTE WITH BOUND TRYPTOPHAN SUBSTRATE
1592, p2yjnB_, 0.5758, 3.63, 0.165, 393, 376, STRUCTURE OF THE GLYCOSYLTRANSFERASE ERYCIII FROM THE ERYTHROMYCIN BIOSYNTHETIC PATHWAY IN COMPLEX WITH ITS ACTIVATING PARTNER ERYCII
1593, p3bdzB1, 0.5757, 3.49, 0.140, 390, 372, THE ROLE OF ASN 242 IN P450CIN
1594, p4oqrA1, 0.5753, 3.49, 0.140, 390, 372, STRUCTURE OF A CYP105AS1 MUTANT IN COMPLEX WITH COMPACTIN
1595, p5yswA1, 0.5749, 3.21, 0.138, 375, 363, CRYSTAL STRUCTURE ANALYSIS OF RIF16 IN COMPLEX WITH R-L 
1596, p4l77B1, 0.5746, 3.73, 0.168, 395, 375, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
1597, p3bdzA1, 0.5743, 3.43, 0.157, 389, 370, THE ROLE OF ASN 242 IN P450CIN
1598, p4lhtA1, 0.5740, 3.50, 0.140, 394, 372, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
1599, p4l77A1, 0.5738, 3.61, 0.155, 397, 373, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
1600, p4l6gA1, 0.5737, 3.61, 0.155, 397, 373, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
1601, p4fyzA1, 0.5737, 3.40, 0.154, 384, 369, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
1602, p4lhtB1, 0.5734, 3.75, 0.177, 386, 373, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
1603, p4fyzB1, 0.5732, 3.56, 0.150, 394, 374, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
1604, p4l6gB1, 0.5729, 3.56, 0.150, 394, 374, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
1605, p3wvsA1, 0.5728, 3.28, 0.156, 383, 360, CRYSTAL STRUCTURE OF CYTOCHROME P450REVI
1606, p5mnsE1, 0.5725, 3.28, 0.156, 383, 360, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1607, p4fmxA1, 0.5725, 3.54, 0.137, 392, 371, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
1608, p1t2bB1, 0.5722, 3.78, 0.139, 386, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
1609, p4fmxB1, 0.5721, 3.73, 0.149, 396, 377, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
1610, p3nc7B1, 0.5719, 3.40, 0.168, 393, 369, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1611, p5mnvF1, 0.5717, 3.65, 0.141, 390, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1612, p1t2bA1, 0.5717, 3.67, 0.147, 393, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
1613, p5livC1, 0.5700, 3.53, 0.133, 389, 369, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1614, p5mnvC1, 0.5695, 3.59, 0.128, 381, 367, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1615, p4tpnA1, 0.5689, 3.48, 0.130, 392, 368, HIGH-RESOLUTION STRUCTURE OF TXTE IN THE ABSENCE OF SUBSTRATE
1616, p5mnsC1, 0.5686, 3.50, 0.136, 388, 368, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1617, p4l36B1, 0.5681, 3.55, 0.142, 390, 372, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1618, p6f8cA1, 0.5675, 3.09, 0.154, 371, 356, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1619, p6f8aB1, 0.5670, 3.19, 0.153, 370, 359, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1620, p6f88A1, 0.5662, 3.60, 0.123, 387, 367, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
1621, p5mnsD1, 0.5655, 3.60, 0.123, 387, 367, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1622, p4fb2A1, 0.5652, 3.78, 0.132, 397, 372, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1623, p4fb2D1, 0.5650, 3.78, 0.132, 397, 372, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1624, p5ex9A2, 0.5648, 3.01, 0.204, 360, 353, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; GLYCEROL CRYO
1625, p5ysmA1, 0.5644, 3.14, 0.164, 379, 359, CRYSTAL STRUCTURE ANALYSIS OF RIF16 
1626, p4fb2B1, 0.5635, 3.05, 0.160, 377, 357, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1627, p5xntA1, 0.5633, 3.28, 0.188, 364, 357, STRUCTURE OF CYP106A2 FROM BACILLUS SP. PAMC 23377
1628, p6f85B1, 0.5631, 3.28, 0.188, 364, 357, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
1629, p5livA1, 0.5629, 3.02, 0.163, 376, 356, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1630, p5mnvE1, 0.5624, 3.27, 0.161, 382, 360, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1631, p3nc7A1, 0.5622, 3.70, 0.138, 383, 369, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1632, p4fb2C1, 0.5617, 3.69, 0.136, 384, 369, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1633, p5ex8A2, 0.5614, 3.00, 0.170, 367, 348, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; ETHYLENE GLYCOL CRYO
1634, p6f8cB1, 0.5609, 3.54, 0.122, 391, 362, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1635, p6f8aA1, 0.5597, 3.71, 0.144, 385, 362, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1636, p5xw2A1, 0.5535, 3.48, 0.162, 380, 359, CRYSTAL STRUCTURE OF THE HYDROXYLASE HMTN IN C 1 2 1 CRYSTAL FORM 
1637, p4zgxG4, 0.5377, 3.15, 0.172, 367, 349, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
